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ABSTRACT
Endocytic membrane trafficking is a basic cell process that is critical for
regulating the transport of lipids and proteins. Our lab focuses on the cellular functions
and mechanisms of the proteins that regulate these pathways. A key family of
regulatory proteins is the C-terminal Eps15 Homology Domain (EHD) protein family.
The EHD family includes EHD1-4, which are ubiquitously expressed in mammalian
tissues. While these isoforms do have some overlapping functions, each protein also has
distinct activities in regulating the shape and fission of membranes throughout the
endocytic pathways. Specifically, EHD1 uses ATP hydrolysis to induce constriction and
fission of endocytic membranes. EHD1 is recruited to tubular recycling endosomes
(TREs) by interacting with Molecules Interacting with CAsL-Like 1 (MICAL-L1) and it
performs fission to release cargo-containing vesicles from the TRE. Our lab
demonstrated that upon EHD1 depletion, the TREs become elongated due to the lack of
fission and the receptors that recycle through this pathway display impaired recycling to
the plasma membrane. Furthermore, our lab and others have shown that EHD1 not only
interacts with MICAL-L1, but also with a variety of other proteins, such as the retromer
cargo selection complex (CSC), which is known to regulate the trafficking of membranes
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and proteins between endosomes and the Golgi complex. Recently, the proposed role of
VPS35, a core protein of the retromer complex, has expanded, and it was found to
interact with and control the mitochondrial fission protein, Drp1. However, the
connection between EHD1 and the retromer and their role in mitochondrial homeostasis
is less clear. It was previously thought that endocytic regulatory proteins exclusively
impacted membrane trafficking pathways, but recent studies suggest that endocytic
regulatory proteins play a role in many other pathways including ciliogenesis,
centrosome disengagement, and mitochondrial homeostasis. Herein, I describe a novel
role for in endocytic regulatory proteins in controlling mitochondrial fission and
mitochondrial-induced apoptosis. My studies led to a model by which EHD1 regulates
the localization of the retromer within the cell; accordingly, when EHD1 is absent, the
retromer no longer regulates the mitochondrial fission protein, Drp1. In addition, I
demonstrate for the first time, a connection between endocytic proteins and apoptosis by
proposing a model for an expanded role for the retromer complex in regulating
mitochondrial-induced apoptosis through the trafficking of the anti-apoptotic protein,
Bcl-xL.
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Chapter I

INTRODUCTION

With permission from Traffic, parts of this chapter were derived from: (Farmer,
Naslavsky, & Caplan, 2018)

Farmer, T., N. Naslavsky, and S. Caplan. 2018. Tying trafficking to fusion and fission at
the mighty mitochondria. Traffic. 19:569-577.
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1. ENDOCYTIC TRAFFICKING
1.1 Overview
The plasma membrane (PM) is a lipid bilayer that forms a permeable barrier
between the intracellular components of a cell and the extracellular environment
(Conner & Schmid, 2003). The PM not only is responsible for the regulation of what
comes in and out of the cell, such as ions or other various molecules, but also mediates
the communication between neighboring cells, and has the ability to receive the
extracellular cues needed for growth and survival. The dynamic connection between
endocytic trafficking and endocytic events is critical for regulating and maintaining the
surface area and protein composition of the PM (G. J. Doherty & McMahon, 2009).
Endocytic membrane trafficking refers to the process by which internalization of
receptors, proteins, and nutrients along with extracellular fluid is enclosed in an
invaginated portion of the PM, resulting in the pinching off of the membrane to form an
endosome or vesicle (Conner & Schmid, 2003). Vesicle formation at the PM can occur
through two distinct pathways, termed clathrin-dependent or clathrin-independent
(described later in detail). No matter which way the lipids and proteins are internalized,
the cargos are packaged into vesicles and delivered to an organelle, known as the early
endosome (EE) or sorting endosome (SE) (Mayor, Presley, & Maxfield, 1993; Mellman,
1996a), where the cargo is initially sorted to determine its final fate. From the EE, the
cargo can be destined for degradation by being transported to late endosomes (LE) and
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eventually the lysosomes, the cargo can be recycled back to the PM, or transported to
trans-Golgi network (TGN). (Figure 1.1)
Endocytic trafficking plays a crucial role in regulating many diverse cellular
processes, including the uptake of nutrients, regulation of surface receptors, cellular
signaling, cytokinesis (Conner & Schmid, 2003; Skop, Bergmann, Mohler, & White,
2001), maintenance of cell polarity, cell adhesion and cell migration (Caswell & Norman,
2008; E. Wang et al., 2000), and synaptic vesicle retrieval in neurons (Kjaerulff,
Verstreken, & Bellen, 2002). Dysregulation of the endocytic pathways have been related
to various diseases, such as different types of cancer, neurodegeneration, and heart
disease (Conner & Schmid, 2003; Stein, Dong, & Wandinger-Ness, 2003). Additionally,
studies have shown that pathogens can exploit distinct endocytic pathways in order for
the host cell to internalize the pathogen more efficiently (Mercer et al., 2010).
Understanding the mechanisms that regulate endocytic pathways will ultimately
provide novel approaches for developing therapeutic strategies and drug development.
1.2 Modes of internalization
Internalization into a cell can occur through multiple pathways and is largely
determined by the size of the molecule or particle that needs to be internalized. For
example, smaller molecules like amino acids, sugars, and ions can enter through
channels and protein pumps embedded into the PM. However, the macromolecules that
are unable to fit through these channels or pumps undergo endocytosis through the
invagination and budding of the PM. Endocytosis can be classified into two main types
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Figure 1.1
Overview of endocytic pathways. Once internalized from the plasma membrane,
membrane-bound vesicles that carry receptors from the cell surface fuse with the
EEs. The EE serves as a sorting station from which either tubulo-vesicular carriers
deliver cargo to the endo-lysosomal system for degradation, or cargos are recycled
directly or indirectly to the plasma membrane via the endocytic recycling
compartment. Used with permission from JCS (Naslavsky & Caplan, 2018).
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based on the size of the internalized endocytic vesicle, phagocytosis or pinocytosis.
Phagocytosis includes the internalization of larger molecules, such as microbial
pathogens or cellular debris (Aderem & Underhill, 1999), while pinocytosis includes the
internalization of fluid and low-molecular-weight solutes (Conner & Schmid, 2003).
Pinocytosis can be further broken down into two categories based on the type of
machinery that is needed at the PM during internalization, clathrin-mediated
endocytosis (CME) (Figure 1.1) or clathrin-independent endocytosis (CIE). Furthermore,
CIE can be subdivided into different types depending on whether caveolae is present
(Conner & Schmid, 2003; Mayor & Pagano, 2007; Mayor, Parton, & Donaldson, 2014).
1.2.1 Clathrin-mediated endocytosis (CME)
CME is the most extensively studied pathway of internalization from the PM.
The founding discoveries of clathrin and clathrin-coated vesicles (CCVs) have shaped
the way we currently think about CME (Pearse & Crowther, 1987). Over the last few
decades, the work of many scientists has shed light on the mechanism by which
receptors bound to their ligands at the PM are internalized into clathrin-coated pits
(CCPs) and eventually form the CCVs (Robinson, 2015; Sorkin, 2004). The formation of
CCVs can be divided into a five-stage process: initiation, cargo selection, coat assembly,
scission, and uncoating. Key to the formation of CCPs and CCVs is the clathrin itself.
During formation of CCPs, the clathrin is unable to bind to the membrane directly and
instead forms a scaffold to recruit a diverse array of clathrin-associated proteins to
complete the downstream internalization events. One key protein that is recruited to the
PM before the assembly of CCPs is Adaptor Protein-2 (AP-2), which acts as a hub for
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interactions between both the cargo and the PM. AP-2 is a complex composed of two
large adaptin subunits-α and β2, one medium-μ2 and one small σ2 subunit (Owen,
Collins, & Evans, 2004). The AP-2 complex is able to recognize two types of motifs on
the cytoplasmic tail of receptors or cargo: 1) tyrosine-based motifs with a consensus
sequence YXXΦ, where Y is a tyrosine residue, X stands for any amino acid residue and
Φ is a bulky hydrophobic amino acid residue, and 2) the dileucine-based sorting signals
with a consensus sequence defined by DXXLL and [DE]XXXL[LI] with D being
aspartate, E being glutamate, L being leucine, and I being isoleucine (Bonifacino &
Traub, 2003; Janvier et al., 2003). The binding site for the tyrosine-based motifs is on the
carboxyl terminus of the μ2 domain (Ohno et al., 1995), while the α/σ2 hemi-complex
and potential β2 subunit bind to the dileucine-based sorting signal sequence
(Chaudhuri, Lindwasser, Smith, Hurley, & Bonifacino, 2007; Doray, Lee, Knisely, Bu, &
Kornfeld, 2007). Along with the AP-2 protein are other specialized adaptor proteins
known as clathrin-associated sorting proteins (CLASPs), that recognize diverse sorting
signals on the respective cargo receptors, thus facilitating a large range of distinct cargos
that can be endocytosed (Traub & Bonifacino, 2013). Furthermore, post-translational
modifications such as phosphorylation and ubiquitination can recruit CLASPs to
receptor tails. Once the cargo is selected and packaged by AP-2 and CLASPs, the
assembly of the clathrin coat is initiated. AP-2 and the accessory proteins recruit clathrin
to the site of internalization at the PM. Clathrin is a trimer of dimers consisting of three
heavy chains and three light chains assembled as a triskelion that has the intrinsic ability
to build a cage-like structure upon invagination of the PM (Kirchhausen, 2000). Once the
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clathrin is recruited to the PM and the cage-like structure begins to form, more accessory
proteins are recruited to generate and stabilize the curvature of the maturing CCPs, such
as the Bin-Amphiphysin-Rvs (BAR) containing proteins (Koch, Westermann, Kessels, &
Qualmann, 2012). Towards the end of the formation of the CCP, a large and modular
guanosine tri-phosphatase (GTPase) known as Dynamin, along with other curvature
sensing proteins including Amphiphysin, Endophilins, and Sorting Nexin (SNX) 9
(SNX9), facilitates the release of CCVs from CCPs (A. Lee, Frank, Marks, & Lemmon,
1999; Vallis, Wigge, Marks, Evans, & McMahon, 1999; van der Bliek et al., 1993; Yoshida
et al., 2004). The Dynamin GTPase oligomerizes around the neck of the CCPs in a collarlike structure and catalyzes guanosine tri-phosphate (GTP) hydrolysis to mediate
membrane fission and generate independent CCVs. After the scission of the CCV from
the PM, the clathrin coat around the vesicle is disassembled by an adenosine triphosphatase (ATPase) known as Heat shock cognate 70 (Hsc70) and its co-factor
Auxillin (Braell, Schlossman, Schmid, & Rothman, 1984; Prasad, Barouch, Greene, &
Eisenberg, 1993; Ungewickell, 1999). The low-density lipoprotein (LDL) receptor and the
iron-laden transferrin receptor (TfR) are examples of signature cargo that are
internalized by CME. (Figure 1.1)
1.2.2 Clathrin-Independent Endocytosis (CIE)
It is thought that CME is the dominant pathway of internalization of cargo into
the cell, however cells are able to utilize a variety of non-CME pathways collectively
termed CIE. A common theme connecting the CIE pathways is the need for a high
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concentration of cholesterol at the PM upon invagination (Mayor & Pagano, 2007;
Sandvig & van Deurs, 1994).
The caveolae-mediated pathway is the most well-known CIE pathway. The
invaginations formed by caveolae are a flask-shape anywhere from 50-100 nm in size.
These invaginations are usually concentrated at the PM in micro-domains containing
cholesterol, sphingolipids, and phosphatidylinositol (4,5)-bisphosphate (PIP2)
(Anderson, 1998; Pitto et al., 2000; Simone, Caplan, & Naslavsky, 2013). Caveolin-1 is a
crucial membrane protein that oligomerizes to form a loop and inserts into the microdomain of the PM in order to form the framework for the flask-shaped membrane that
comprises the caveolae. Once the Caveolin-1 inserts itself into the PM, it recruits cavin
proteins (cavin 1-4), which in turn help stabilize and build the budding caveolar vesicle
(Hansen, Bright, Howard, & Nichols, 2009; Hill et al., 2008). In addition to Caveolin-1
and the cavin proteins, Syndapin2 (also known as Pacsin2), is recruited to the
invagination. Syndapin2 is a BAR domain-containing protein that can regulate
membrane curvature and helps shape the caveolar invagination (Koch et al., 2012; Senju,
Itoh, Takano, Hamada, & Suetsugu, 2011). Syndapin2 also has a Src homology 3 (SH3)
domain that allows it to bind the proline-rich domain (PRD) of the dynamin GTPase and
a tripeptide sequence containing asparagine-proline-phenylalanine (NPF) motif that
facilitates the binding of Syndapin2 with C-terminal Eps15 homology domain containing
(EHD) protein 2 (EHD2). EHD2 is required for caveolar stabilization at the PM but
previous studies in our lab have shown that whereas Syndapin2 is not required for
EHD2 recruitment, PIP2 levels in the PM are critical for recruitment (Moren et al., 2012;
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Simone et al., 2013; Stoeber et al., 2012). Certain cell types, such as smooth muscle cells,
fibroblast, adipocytes, and endothelial cells, are enriched in caveolae-associated
invaginations (Parton & Simons, 2007). Some examples of the cargo that can be
internalized through the caveolae-mediated pathway include simian virus 40 (SV40)
virions, cholera toxin β subunit (CTxβ), and glycosylphosphatidylinositol (GPI)-linked
proteins (Cheng, Singh, Marks, & Pagano, 2006; Parton & Simons, 2007).
1.2.3 Clathrin-Independent Carriers/GPI-AP-enriched early endosomal compartment
(GLIC/GEEC)
Proteins that are secured to the PM by GPI-anchor-linked proteins (GPI-AP) do
not depend on clathrin or caveolin coats to be internalized but they still require the
cholesterol enriched micro-domains that can be found at the PM (Lakhan, Sabharanjak,
& De, 2009). GPI-APs are internalized through EE-like structures that are highly
enriched in GPI-AP. These EE-like structures are called GPI-AP-enriched early
endosomal compartments (GEEC). The GEECs are formed by the fusion process
between cell surface-derived clathrin-independent tubulovesicular intermediates termed
CLICs (Kirkham et al., 2005). In order to form CLICs, two small GTPases must be
present: cell cycle dependent 42 (Cdc42) and adenosine di-phosphate (ADP)-ribosylation
factor 1 (Arf1) (Kumari & Mayor, 2008). Unlike the pathways mentioned previously,
these structures are dynamin-independent and the mechanism of budding in these
vesicles remains unclear. However, recently a marker of these CLICs was identified as a
protein called GTPase regulator associated with focal adhesion kinase-1 (GRAF1).
GRAF1 has distinct domains that are critical for generating CLICs, such as a scission-
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BAR domain for membrane curving, a pleckstrin homology (PH) domain that allows
GRAF1 to directly bind to PIP2 in the PM, and an SH3 domain that can bind to the PRD
of dynamin (Lundmark et al., 2008). Additionally, work from our lab has provided
evidence for a model suggesting that GRAF1 forms a vesiculation complex that is
comprised of Molecules Interacting with CAsL-Like 1 (MICAL-L1) and C-terminal
Eps15 homology domain containing (EHD) protein 1 (EHD1) on tubular recycling
endosomes (TRE), which in turn helps support TRE vesiculation (Cai, Caplan, &
Naslavsky, 2012; Cai, Xie, Caplan, & Naslavsky, 2014). This may suggest that a
vesiculation complex generated by GRAF1 could be the potential vesiculator of CLICs.
GPI-APs, CTxβ, and fluid phase markers are some examples of known cargos that go
through this pathway (Mayor & Pagano, 2007) (G. J. Doherty & McMahon, 2009).
1.2.4 Arf6 mediated pathway
Another pathway considered to be clathrin-independent is associated with the
ATPase, ADP-ribosylation factor 6 (Arf6). Arf6 can be found at the PM where it
regulates the rate of trafficking in and out of the cell as well as the dynamics of the actin
cytoskeleton near the PM. The mechanism for Arf6 regulation of internalization is by
activating phosphatidylinositol 4,5 kinase (PI5K), which in turn generates PIP2 at the
PM, resulting in enriched PIP2 budding vesicles. Since Arf6 stimulates the production of
PIP2, the latter is able to activate the machinery needed for actin polymerization, thus
driving the endocytic pathway. GPI-APs, CD59, CD55, and major histocompatibility
complex class I (MHC I) proteins are cargo known to internalize through this pathway
(Naslavsky, Weigert, & Donaldson, 2003).
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1.2.5 CIE of interleukin-2 receptor
Another less common CIE pathway is the mechanism used to internalize the
interleukin-2 (IL-2) receptor. IL-2 concentration and internalization occurs through a
small non-coated invagination that depends on RhoA and consequently ras-related C3
botulinum toxin substrate 1 (Rac1) (Gesbert, Sauvonnet, & Dautry-Varsat, 2004; Lamaze
et al., 2001; Mayor et al., 2014). Internalization of IL-2 occurs in detergent-resistant
microdomains of the PM and requires dynamin as well as proteins that regulate actin
polymerization, such as phosphatidylinositol 3-kinase (PI3K), Rac1, Rac1’s guanine
exchange factor Vav2, kinases Pak1 and Pak2, endocytic adaptor cortactin, and Arp2/3
stimulator N-WASP (Basquin et al., 2013; Basquin & Sauvonnet, 2013; Grassart,
Dujeancourt, Lazarow, Dautry-Varsat, & Sauvonnet, 2008; Lamaze et al., 2001). PI3K
plays a key role as its regulatory subunit, p85, associates with the IL-2 receptor and
activates the recruitment of its catalytic p110 subunit to produce PI(3,4,5)P3
(Cendrowski, Maminska, & Miaczynska, 2016). This induces that activation of Rac1 by
Vav2, which in turn is recruited to the IL-2 receptor that is bound to the PI3K and
stimulates Pak1 and Pak2 kinases (Cendrowski et al., 2016). The kinases promote actin
polymerization through cortactin and N-Wasp (Basquin & Sauvonnet, 2013). The
activation of these proteins likely occurs at the last step of internalization and is critical
for vesicle scission from the PM.
1.3 Sorting at the Early Endosome (EE)/Sorting Endosome (SE)
The EE is responsible for receiving vesicles from the PM so that cargo can be
sorted and directed to the correct cellular destination (Jovic, Sharma, Rahajeng, &
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Caplan, 2010). While many proteins localize to EE and are required for proper function,
Rab5, a member of the Ras-associated binding (Rab) small GTPases, marks EE and
controls the function, dynamics, and subsequent organelle transport of EE (Woodman,
2000). Active Rab5 or GTP-bound Rab5 recruits a number of Rab5 effectors that include
the phosphatidyl inositol-4-5 bisphosphate-3-kinase (PI3K), promoting the generation of
phosphoinositol 4-phosphate (PI3P) at the EE. PI3P in the EE membrane allows
recruitment of proteins that contain a FYVE domain (Stenmark, Aasland, & Driscoll,
2002). Examples of FYVE domain-containing proteins include Early Endosomal
Autoantigen-1 (EEA1), Rabankyrin-5, and Rabenoysn-5, which also interact with Rab5
(Grosshans, Ortiz, & Novick, 2006), suggesting that more than a single mechanism exists
to recruit these proteins to the EE.
EE have a mildly acidic lumen between pH 6.3-6.5 and the acidity is important
for disrupting the coupling between the ligands and their receptors within the first few
moments of internalization. This uncoupling of the ligand from the receptor is the first
step in cargo sorting (Maxfield & McGraw, 2004). Additionally, the Rab-5-dependent
recruitment of a diverse number of effector proteins encourages the differentiation of the
EE from a small vesicular structure to a rather large structure that has both a vacuolar
and tubular component to it (Huotari & Helenius, 2011). This differentiation is due to
the fact that EE are highly dynamic and undergo homotypic fusion (Gruenberg et al.
1989). The formation of both vacuolar and tubular components provides subdomains
within the EE that allow for efficient sorting of cargos (Mayor et al., 1993). For example,
cargo clustered in the tubular areas of the EE is usually targeted for recycling back to the
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PM, whereas cargo inside the more bulky vesicles is usually sent to the lysosome for
degradation by way of multi-vesicular bodies (MVBs) (Mellman, 1996b). Frequently, the
internalized receptor is recycled back to the PM to bind with another ligand, while the
ligand is transported to the lysosome for degradation (Maxfield & McGraw, 2004). For
instance, TfR and LDL receptors are recycled back to the PM upon entering the EE,
while the transferin (Tf) and LDL itself are transported to the lysosome for degradation
(Jovic, Kieken, Naslavsky, Sorgen, & Caplan, 2009). (Figure 1.1)
1.4 Sorting cargos to the LE/lysosome for degradation
As previously mentioned above, the EE is responsible for regulating the sorting
of ligands and signaling receptors that have been internalized from the PM. The ligands
that have uncoupled from their receptors and become soluble are typically sorted for
degradation by a maturation pathway beginning with EE and advancing to LE.
However, the transmembrane receptors must be sorted by their sorting signals located
in the cytosolic domain of the receptor. A frequently studied receptor is the Epidermal
Growth Factor Receptor (EGFR), a tyrosine kinase (RTK) that has a specific cytosolic
domain recognized by sorting machinery that targets it to the degradation pathway
(Haglund et al., 2003). The sorting of the EGFR is done by post-translational
ubiquitination of one or more of the lysine residues in its cytoplasmic tail, in turn
marking it for degradation through the lysosome (Haglund et al., 2003; Huang,
Kirkpatrick, Jiang, Gygi, & Sorkin, 2006; Levkowitz et al., 1998; Umebayashi, Stenmark,
& Yoshimori, 2008). Once the receptor is marked with ubiquitin, several proteins that
interact with ubiquitin through ubiquitin-interacting motifs (UIM) recognize the
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receptor. These proteins include the endosomal sorting complexes required for
transport-0 (ESCRT-0), hepatocyte growth factor regulated tyrosine kinase substrate
(Hrs), signal transducing adaptor molecule 2 (STAM2) and the ESCRT-I component, and
tumor susceptibility gene 101 (TSG101) (Raiborg & Stenmark, 2002). In parallel, the
ESCRT-1 component and Tsg101 promote the recruitment of the ESCRT-II complex. This
event is needed to initiate the budding of MVBs. The ESCRT-II triggers the
oligomerization of the ESCRT-III complex on the endosomal membrane, which allows
for the capture of the cargo to novel MVB and also catalyzes the scission of the MVB
(Babst, Katzmann, Estepa-Sabal, Meerloo, & Emr, 2002; Babst, Katzmann, Snyder,
Wendland, & Emr, 2002). Upon completion of MVB formation, vacuolar sorting protein
(VPS) 4 (VPS4), an ATPase, is recruited to catalyze the disassembly of the ESCRT-III
complex from the newly formed MVB. The newly formed MVB can then fuse with the
LE or lysosome, resulting in the degradation of the EGFR and other sorted receptors
(Shestakova et al., 2010). Our lab has been able to establish a novel role for C-terminal
Eps15 homology domain containing (EHD) protein 4 (EHD4) in the trafficking of
receptors from the EE to the lysosomes (Sharma, Naslavsky, & Caplan, 2008).
1.5 Sorting cargos for recycling back to the PM
Cargos that are selected to return back to the PM can do so via two routes. The
first route is through the “fast recycling” pathway. Fast recycling refers to the recycling
of receptors back to the PM directly from the EE. However, most of the receptors travel
from the EE to an additional organelle termed the endocytic recycling compartment
(ERC). The ERC is localized near the microtubule organizing center (MTOC) in the
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perinuclear area of the cell (B. D. Grant & Donaldson, 2009; Maxfield & McGraw, 2004).
Rab4 and Rab11 are the most prominent markers for differentiating between the fast and
slow recycling pathways, respectively (Ullrich, Reinsch, Urbe, Zerial, & Parton, 1996;
Van Der Sluijs et al., 1991).
The composition, structure, and functional mechanism of the ERC in endocytic
recycling are poorly understood despite the importance of the ERC in the recycling
process. Recent studies from our lab took advantage of super resolution microscopy,
Structured Illumination Microscopy (SIM), dual channel 2D-direct Stochastic Optical
Reconstruction Microscopy (dSTORM), and 3D STORM, in order to address ERC
morphology and cargo selection. The studies showed that the ERC is composed of an
array of dynamic, densely situated but independent tubular and vesicular recycling
endosomes coming from the MTOC (Xie et al., 2016). It has been established that due to
the high surface area-to-volume ratio displayed in the ERC, this facilitates segregation of
the integral membrane protein cargo from their luminal content (Maxfield & McGraw,
2004). However, studies in our lab show that the ERC maintains cargo separation that
has occurred in the EE, suggesting that the ERC serves as a focal point for vesicular
transport to the PM (Xie et al., 2016).
TREs, found within the ERC, are critical for the recycling of internalized receptors and
lipids. Previous studies from our lab have shown that MICAL-L1-decorated TREs can be
generated from areas of the EE that are enriched in a Rab-5 effector known as
Rabenosyn-5 (Xie et al., 2016). Furthermore, our lab’s current model suggests that the
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fission of TREs leads to the formation of vesicle carriers that transport the receptor back
to the PM (Cai et al., 2012; Cai et al., 2013; Cai et al., 2014). Adding to the significance of
TREs, our lab as extensively studied the players involved in TRE generation, fission,
fusion, and function. Previous studies from our lab have been able to demonstrate that
MICAL-L1 localizes to TRE (Sharma, Jovic, et al., 2009) and acts as a hub that recruits
and stabilizes multiple proteins that can impact the shape of the TREs. For example, the
F-BAR domain containing protein Syndapin2 interacts with MICAL-L1 and bends
endosomal membranes to generate TREs (Giridharan, Cai, Vitale, Naslavsky, & Caplan,
2013). MICAL-L1 also interacts with the C-terminal Eps15 homology domain containing
(EHD) protein 3 (EHD3) and EHD1 (Kieken et al., 2010; Sharma, Jovic, et al., 2009).
EHD3 and EHD1 are responsible for the stabilization and vesiculation of the TREs,
respectively (Bahl et al., 2016; Cai et al., 2013). Another critical aspect to TREs is the high
concentration of phosphatidic acid (PA), an essential lipid component of the TRE
membrane that allows for the binding with MICAL-L1 and Syndapin2. EHD1
subsequently binds to the MICAL-L1 and Syndapin2 complex on the TRE, and induces
scission of these membranes, generating a newly synthesized vesicle (Cai et al., 2013; Cai
et al., 2014; Giridharan et al., 2013). (Figure 1.2)
1.6 Sorted cargos destined for the trans-Golgi network (TGN)
EEs are not only important for sorting receptors and ligands to the recycling or
degradation pathway but are also important for the tethering of various endocytic and
biosynthetic pathways. Transport from the EE to the TGN is known as retrograde
transport. (Figure 1.1) While retromer-mediated tubulation is required for retrograde
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Figure 1.2
Model for biogenesis of tubular recycling endosomes. (A) Phosphatidic acid is
generated or enriched on membranes. (B) MICAL-L1 (via its CC domain) and Synd2
(via its F-BAR domain) are recruited to PA-enriched membranes. (C) The MICAL-L1
PXXP motifs interact with the SH3 domain of Synd2 to stabilize both proteins on the
membranes and (D) facilitate the generation of tubular endosomes by Synd2. (E)
Synd2 and MICAL-L1 bind to the EH domain of EHD1 via their NPF motifs and
recruit EHD1 to these tubular membranes, potentially facilitating vesiculation. Used
with permission from MBoC (Giridharan et al., 2013).
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transport, these tubules are distinct from the TREs that facilitate the recycling process
previously described (Bonifacino & Rojas, 2006). The machinery that is necessary for
retrograde transport is recruited to EEs that are in the process of maturation and
evolving into LE and therefore contain a higher concentration of phosphatidylinositol
3,5, bisphosphate (PI(3,5)P2) and have an increasing number of intraluminal vesicles
(ILVs).
Initial studies by Seaman and coworkers in the yeast endolysosomal system were
instrumental in the identification of the protein complex called the “retromer” (Seaman,
McCaffery, & Emr, 1998). The retromer was proposed to mediate the endosome-to-TGN
retrieval of the vacuolar hydrolase receptor, Vps10p, which is the yeast equivalent of the
mannose 6-phosphate (M6PR) receptor. The retromer consists of a hetero-pentameric
complex consisting of a SNX dimer composed of SNX1/2 or Snx5/6 and a trimer
consisting of vacuolar protein sorting 35 (VPS35), vacuolar protein sorting 26 (VPS26),
and vacuolar protein sorting 29 (VPS29) (Bonifacino & Hurley, 2008; Bonifacino & Rojas,
2006; Rojas et al., 2008; Seaman, 2005). Initially the trimer of VPS35, VPS26, and VPS29
was thought to be involved in the cargo sorting, while the SNX dimer was responsible
for binding to the EE membrane by the phox-homology (PX) domain contained within
the SNX proteins, therefore acting as a scaffold (Bonifacino & Rojas, 2006). However, the
structure of the retromer complex has recently been described using cryo-elctron
tomography and subtomogram averaging to highlight the retromer as a structure that
forms arches that extend away from the membrane surface (Kovtun et al., 2018). Based
on these structures, it is thought that the trimer of VPS proteins forms a scaffold and the
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distinct combination of SNX proteins associated with the retromer controls the cargo
sorting function (Kovtun et al., 2018). While the exact mechanism detailing how the
retromer sorts cargo destined for the TGN is yet to be determined, it has been
established that the cargo within these endosomes contain at least one simple
hydrophobic motif comprised of phenylalanine/tryptophan-leucine-methionine/valine
(F/W-L-M/V) (Gokool, Tattersall, & Seaman, 2007). The most well studied cargos that are
transported through the retrograde transport include the vacuolar hydrolase transport
receptors, VPS10 in yeast or M6PR in mammals (Bonifacino & Rojas, 2006; Johannes &
Popoff, 2008).
EHD1 is also an important regulator of the retromer-mediated transport of
cargos from EEs to the TGN. EHD1 co-localizes and interacts with the VPS26 and VPS35
subunits of the retromer and impacts the retrieval of the M6PR back to the TGN (Gokool
et al., 2007). While we have observed co-localization and interactions between EHD1,
VPS35, and VPS26, it has yet to be determined if this interaction is direct or indirect.
However, work from our lab suggests that Rabankyrin-5, a Rab5 effector that binds
directly to EHD1 through a MPF motif, also interacts with the retromer complex,
potentially mediating the interaction between EHD1 and the retromer (McKenzie et al.,
2012; Zhang, Naslavsky, & Caplan, 2012; Zhang, Reiling, et al., 2012). It is also important
to note that our lab found EHD3, the closest paralog of EHD1, mediates the transport of
cargo from the EE to TGN (Naslavsky, McKenzie, Altan-Bonnet, Sheff, & Caplan, 2009).
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2. REGULATORS OF ENDOCYTIC TRAFFICKING
2.1 Overview
Endocytic trafficking of cargos is very important and critical function for the cell
to maintain homeostasis; therefore the process is highly regulated by multiple types of
proteins, such as Rab GTPases, soluble N-ethylmaleimide-sensitive factor attachment
protein receptors (SNARE) fusion machinery proteins, fission proteins such as EHD1,
coat proteins, and many more. These proteins work together to actively internalize, sort,
degrade, and recycle internalized cargo.
Rab GTPases are a family of more than 60 small Ras-related GTP-binding
proteins that control endocytic trafficking steps and localize to the endocytic organelles,
such as the EE or LE (Pfeffer & Aivazian, 2004). When a Rab is bound to GDP, the Rab
usually becomes cytosolic and inactive, while GTP-bound Rabs are usually active and
bound to the endocytic membranes. When Rab proteins are bound to the endocytic
membranes they are able to recruit Rab effector proteins that regulate the membrane
lipid content, membrane fusion/fission, and transport along the cytoskeleton (Pfeffer &
Aivazian, 2004).
Another class of proteins that is critical for the transport of vesicles from one
destination to another in the endocytic pathway is the SNARE family of proteins.
SNARE proteins located on the vesicle are termed v-SNAREs and the vesicles target
membrane are termed t-SNAREs. Together, the v-SNARE and t-SNARE provide the
required energy for the fusion of the transport vesicle and the target membrane.
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The EHD family of proteins consists of four highly homologous membraneassociated ATPases that are able to regulate membrane tubule and vesicle formation by
means of their interaction partners. It has been well documented that if these EHD
proteins are depleted or mutated, cargos are not efficiently transported between
endocytic compartments (Naslavsky & Caplan, 2011). While the EHD1-4 family of
proteins shares high sequence homology, each protein retains separate functionality in
its regulation of the endocytic pathway.
2.2. Rab GTPases and their effector proteins
Among the various proteins needed to regulate endocytic trafficking, the small
Rab proteins play a major role. During a Rab GTPase cycle, the GDP-bound Rab protein
is considered inactive and associates with Guanosine nucleotide dissociation inhibitors
(GDIs), which are located in the cytosol. In order for the Rab to unbind from the GDI in
the cytosol, a GDI displacement factor (GDF) must release the Rab so it can be recruited
to the endocytic membrane. Once the Rab becomes GTP-bound, it interacts with a series
of specific protein effectors that include but are not limited to tethering molecules,
kinases, phosphatases, adaptor proteins, and motor proteins that help the Rab carry out
its function of fission, fusion, and tethering. A GTP-bound Rab can become inactive and
disassociate from endocytic membranes by its specific GTPase-activating proteins
(GAPs). GAPs work by facilitating GTP hydrolysis, making the Rab become GDP-bound
and completing the Rab cycle. (Figure 1.3)
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The Rab proteins that are associated with the EE mediate the function of postinternalization sorting and include Rab4, Rab5, Rab10, Rab11, and Rab22 (Babbey et al.,
2006; Magadan, Barbieri, Mesa, Stahl, & Mayorga, 2006; Van Der Sluijs et al., 1991). As
mentioned previously, Rab5 is the most extensively studied Rab on EE and commonly
used as a marker of this organelle. (Barbieri, Roberts, Mukhopadhyay, & Stahl, 1996;
Bucci et al., 1992; Gorvel, Chavrier, Zerial, & Gruenberg, 1991; Grosshans et al., 2006;
Zerial & McBride, 2001). It is thought that Rab5 controls trafficking by regulating the
composition of the membrane to include more PI3P (Christoforidis et al., 1999; Murray,
Panaretou, Stenmark, Miaczynska, & Backer, 2002), promoting homotypic fusion
(Gorvel et al., 1991) and facilitating the EE on cytoskeletal tracks (Nielsen, Severin,
Backer, Hyman, & Zerial, 1999; Pal, Severin, Lommer, Shevchenko, & Zerial, 2006). For
the Rab5 to become active and GTP-bound, the guanine exchange factor (GEF), Rabex-5,
must be present at the EE to activate Rab5 (Horiuchi et al., 1997). GTP-bound Rab5
recruits Rab5 effector proteins to the membrane of the EE, where their specialized
function in the sorting or trafficking of cargos can take place (Grosshans et al., 2006).
Some of the key Rab5 effectors include PI3K (Christoforidis et al., 1999), EEA1
(Merithew, Stone, Eathiraj, & Lambright, 2003), Rabenosyn-5 (Nielsen et al., 2000) and
Adaptor protein containing PH domain (APPL1 and APPL2) (Miaczynska et al., 2004).
The PI3K leads to increased PIP2 in the endocytic membrane, which allows the
recruitment of proteins (Gillooly et al., 2000; Siddhanta & Shields, 1998). EEA1 and
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Figure 1. 3
The Rab switch and its circuitry. Conversion of the GDP-bound Rab into the GTPbound form occurs through the exchange of GDP for GTP, which is catalysed by a
guanine nucleotide exchange factor (GEF) and causes a conformational change. The
GTP-bound 'active' conformation is recognized by multiple effector proteins and is
converted back to the GDP-bound 'inactive' form through hydrolysis of GTP, which
is stimulated by a GTPase-activating protein (GAP) and releases an inorganic
phosphate (Pi). The newly synthesized Rab, in the GDP-bound form, is recognized
by a Rab escort protein (REP). The REP presents the Rab to a geranylgeranyl
transferase (GGT), which geranylgeranylates the Rab on one or two carboxy-terminal
Cys residues. The geranylgeranylated, GDP-bound Rab is recognized by Rab GDP
dissociation inhibitor (GDI), which regulates the membrane cycle of the Rab.
Targeting of the Rab–GDI complex to specific membranes is mediated by interaction
with a membrane-bound GDI displacement factor (GDF). Used with permission from
Nature review (Stenmark, 2009).
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Rabenosyn-5 both bind to PI3P in the membrane through their FYVE domain. EEA1
subsequently recruits Syntaxin13 and Syntaxin6, which facilitate EE fusion with other
endocytic membranes later in the pathway (McBride et al., 1999; Simonsen, Gaullier,
D'Arrigo, & Stenmark, 1999). Rabenosyn-5 on the endocytic membrane binds human
vacuolar protein sorting 45 (hVPS45), which in turn binds to v-SNARE proteins and
leads to fusion of the EE with target membranes (Naslavsky et al., 2009). Along with
Rab5 and Rab5 effectors on EE, Rab4 is also localized to the EE (Van Der Sluijs et al.,
1991). Rab4 is responsible for the direct exit of the recycling cargo containing vesicles
from EE to the PM, known as fast recycling, as well as being able to sort these same
cargos to the ERC (Sheff, Daro, Hull, & Mellman, 1999; Van Der Sluijs et al., 1991).
Upon maturation of the EE to a LE, the exchange of Rab5 with Rab7 is a key
event (Peralta, Martin, & Edinger, 2010). Rab7 is recruited the EE membrane by
homotypic fusion and by interacting with vacuole protein sorting (HOPS) subunit
Vam6p/VPS39 (Caplan, Hartnell, Aguilar, Naslavsky, & Bonifacino, 2001; Wurmser,
Sato, & Emr, 2000). The VPS39 protein interacts with a protein that binds to GTP-bound
Rab5, Mon1, and displaces the Rabex-5 GEF protein from the membrane. The Mon1,
along with its interaction partner, Czi1, can recruit Rab7 to the EE. The Mon1/Czi1
interaction prevents Rab5 from becoming activated again and also promotes the
activation of the newly acquired Rab7, thus promoting the maturation of the EE to a LE
(Nordmann et al., 2010). Similar to Rab5, Rab7 also has effector proteins that are
recruited to the LE to perform specialized functions. Rab7-interacting lysosomal protein
(RILP), is recruited to the LE and in turn recruits dynein-dynactin motor proteins that
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allow for transport of the LE toward the minus end of the microtubules (Cantalupo,
Alifano, Roberti, Bruni, & Bucci, 2001). The previously mentioned HOPs complex
remains in contact with Rab7- positive LE and promotes tethering and fusion of the LE
with target membranes through SNARE proteins.
A number of other Rab proteins play a role in regulating various steps in the
endocytic pathway and include Rab11, Rab21, Rab 22, Rab8, Rab15, Rab35, (B. D. Grant
& Donaldson, 2009; Grosshans et al., 2006; V. W. Hsu & Prekeris, 2010), and it was
recently found that Rab10 associates with MICAL-L1 and localizes to TREs; however the
function of Rab10 on the TRE is still being explored (Etoh & Fukuda, 2019). Not only are
the Rab proteins present in the endocytic pathway, but the Rab effector proteins as well
(Grosshans et al., 2006). Some of the Rab effector proteins are also able to interact with
the aforementioned EHD1 protein (Naslavsky & Caplan, 2011). As previously
mentioned, Rab4 is a well-known regulator of fast recycling from EE back to the PM,
and Rab4 alone does not access the ERC. However, if Rab4 and Rab11 are both located
on the EE, it can lead to the delivery of the cargo to ERC (Sonnichsen, De Renzis,
Nielsen, Rietdorf, & Zerial, 2000). Rab11 binds to its effector proteins, Rab11 familyinteracting protein 5 (FIP5) and Rab11-FIP2, which in turn recruit important players of
the slow recycling pathway. These proteins include the kinesin II motor protein, KIF3B
(Schonteich et al., 2008), myosin Vb (Roland, Kenworthy, Peranen, Caplan, &
Goldenring, 2007), EHD1, and EHD3 (Naslavsky, Rahajeng, Sharma, Jovic, & Caplan,
2006). Similar to Rab4 function, Rab35 is able to promote the fast recycling of receptors
(Allaire et al., 2010; Sato et al., 2008). However, Rab35 and its effector protein, MICAL-
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L1, can localize to TRE and serve as scaffolding proteins to recruit various proteins that
are critical to TRE homeostasis, such as EHD1 (Giridharan, Cai, Naslavsky, & Caplan,
2012). Besides these Rab proteins and their effectors, other types of Rab proteins play a
role in the slow recycling pathway. For example, Rab8 is recruited to TRE by MICAL-L1
and is involved in the Rab11-Rab8-Myosin Vb complex that recycles cargos back to the
PM (Huber et al., 1993; Roland et al., 2007). Rab22a is also found on tubules generated
from the ERC and plays a role in mediating tubule generation and the fusion of
recycling endosome membranes and the PM (Weigert, Yeung, Li, & Donaldson, 2004).
Rab22a may also play a role in cargo selection within the slow recycling pathway as it
preferentially traffics the MHC 1 protein and has little effect on the Tf receptor.
While Rab proteins play a major role in endocytic trafficking, there is another
family of proteins that are also guanine nucleotide-binding proteins termed ADPribosylation factor (Arf) proteins. The Arf proteins regulate organelle dynamics and
membrane trafficking in a similar manner to that of Rab proteins (Donaldson & Jackson,
2000). Arf proteins can be divided into different classes with the class 1 (Arf1-3) group of
Arf proteins mediating the trafficking between the ER-to-Golgi (D'Souza-Schorey &
Chavrier, 2006). On the other hand, the class III group of Arf proteins (Arf6) stimulates
endocytosis by promoting the invagination of the PM (Naslavsky et al., 2003). As
previously mentioned, Arf6 functions more as a lipid and cytoskeleton modifier by the
activation of PI5K, which in turn enriches the membrane in PIP2. PIP2 enrichment at the
PM promotes membrane trafficking and actin rearrangement (Czech, 2003; Yin &
Janmey, 2003). Arf6 is responsible for the internalization of cargos such as MHCI, G
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protein-coupled receptors, E-cadherin and β1-integrin (Brown, Campbell, & Sanderson,
2001; Houndolo, Boulay, & Claing, 2005; Naslavsky et al., 2003; Radhakrishna &
Donaldson, 1997). Arf6 also coordinates with EHD1 to mediate the MHCI-containing
TRE and the localization of Rab8 and MICAL-L1 to tubular membranes (Caplan et al.,
2002; Rahajeng, Giridharan, Cai, Naslavsky, & Caplan, 2012).
2.3 v-SNARE and t-SNARE proteins
In general, the soluble N-ethylmaleimide-sensitive factor attachment receptor
(SNARE) proteins mediate fusion events of two membranes by utilizing the SNARE
motif that resides in each protein (Bennett, 1995; Fasshauer, 2003; Sollner, 1995). The
SNARE motif consists of a helix-forming structure that has an evolutionarily conserved
domain of 60-70 amino acids, along with heptad repeats. In order for two endocytic
membranes to fuse using SNARE proteins, the vesicle membrane SNARE (v-SNARE)
interacts with the target membrane SNARE (t-SNARE) by association with the SNARE
motifs found in each protein. This association forms a four-helical bundle that is
extremely stable and provides the energy to undergo fusion of the vesicle with the target
membrane (Y. A. Chen & Scheller, 2001; Sutton, Fasshauer, Jahn, & Brunger, 1998). Some
specific examples of SNARE proteins that are involved in the homotypic fusion of EE is
syntaxin13, VPS10p tail interactor 1 (vit1a), syntaxin6, and VAMP4 (Brandhorst et al.,
2006; Zwilling et al., 2007). The Rab5 effector, EEA1, plays a major role in recruiting
SNARE proteins to the EE and if the recruitment of EEA1 is disrupted by PI3K
inhibition, the activity of EEA1 is impaired, leading to EE that are unable to fuse
properly (McBride et al., 1999; Simonsen et al., 1999). Like many other complexes, once
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the fusion of homotypic EE is completed, the complex must be disassembled. The
disassembly of the SNARE complex is regulated by AAA+ (ATPases Associated with
diverse cellular Activities) protein N-ethylmaleimide-sensitive factor (NSF) (Hanson &
Whiteheart, 2005; Mayer, Wickner, & Haas, 1996). The disassembly of the SNARE
complex is initiated by the binding of 3 NSF attachment proteins (SNAP) with the fourhelical bundle generated from the fusion of the v-SNARE and t-SNARE and uses the
energy from ATP hydrolysis to break the bundle apart (Sollner, 1995). (Figure 1.4)
2.4 C-terminal Eps15 homology domain (EHD) protein family
The mammalian EHD family is comprised of four proteins, EHD1-4. This family
of proteins has the ability to homo- and hetero-oligomerize and helps facilitate their
function in the membrane trafficking pathway (B. D. Grant & Caplan, 2008; Pohl et al.,
2000). The EHD proteins are highly conserved at the amino acid level across many
species. For example, the EHD family member in C. elegans, RME-1, is 67% identical to
the human EHD1 amino acid sequence. Furthermore, mammalian EHD1 and EHD3
share roughly 86% sequence identity, yet are able to perform specific functions (B. D.
Grant & Caplan, 2008). No matter the species, the EHD proteins share a highly
conserved domain architecture consisting of an N-terminal G-domain, a central helical
region and a C-terminal EH domain. The EHD proteins became a highly interesting
topic of study when EHD1 and RME-1 were found to be crucial in regulating endocytic
recycling in human cells and in C. elegans (Caplan et al., 2002; B. Grant et al., 2001).
(Figure 1.5)

29

Figure 1.4
Schematic representation of the steps of vesicle transport. (A) Coat proteins are
recruited to the cytosolic face of the donor membrane and induce the formation of a
vesicle. The coat recruits SNAREs and transmembrane receptors bound to their
cargo. (B) After uncoating, motor protein can be recruited to enable the vesicle to
travel along microtubules or actin filaments. (c) Once at its destination, the vesicle
becomes tethered to the acceptor membrane, probably by long coiled-coil proteins or
multimeric tethering complexes. (D) The SNAREs on the vesicle and acceptor
membrane form a complex which drives membrane fusion and hence delivery of the
contents of the vesicle. Used with permission from Nature (Behnia & Munro, 2005).
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2.4.1 EHD1
EHD1 is the best characterized EHD protein and is unique in its localization to
TREs involved in endocytic recycling (B. D. Grant & Caplan, 2008; Naslavsky & Caplan,
2011). EHD1 regulates the recycling of many receptors that inter the cell through CME
and CIE. Cargo that is regulated by EHD1 includes the transferrin receptor (TfR) (Lin,
Grant, Hirsh, & Maxfield, 2001), major histocompatibility complex class I proteins (MHC
I) (Caplan et al., 2002), the insulin-regulated GLUT4 transporters (Guilherme, Soriano,
Furcinitti, & Czech, 2004), the cystic fibrosis transmembrane conductance regulator (Lin
et al., 2001), AMPA type glutamate receptors (Park, Penick, Edwards, Kauer, & Ehlers,
2004), MHC class II molecules (Walseng, Bakke, & Roche, 2008), the hyperpolarizationactivated cyclic nucleotide-gated (HCN) ion channel family members HCN1, HCN2 and
HCN4 (Hardel, Harmel, Zolles, Fakler, & Klocker, 2008), G-protein-activated inwardly
rectifying potassium channels (Chung, Qian, Ehlers, Jan, & Jan, 2009), and the calciumactivated potassium channel KCa2.3 (Gao et al., 2010), and other channels (Guilherme et
al., 2004). EHD1 and the Rab11 effector protein, Rab11-FIP2, interacts and localizes to
peripheral EE (Naslavsky et al., 2006). This relationship, along with Rab35, suggests a
role for EHD1 in the transport of cargo from the EE to the ERC in some capacity (Allaire
et al., 2010; Sato et al., 2008). It is known that EHD1 is linked with dynein motors via
collapsing response mediator protein-2 (Crmp2), which in turn regulates the cargo
trafficking from the EE to the ERC (Rahajeng, Giridharan, Naslavsky, & Caplan, 2010).
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Figure 1.5
Role of EHD proteins in membrane trafficking. The four EHD proteins display
considerable sequence identity, from ∼68–87%, and have been implicated in
membrane remodeling (table inset). EHD1, EHD3 and EHD4 have been
characterized in the regulation of endosomal transport, primarily at the EE, with
EHD1 additionally involved in the regulation of recycling from the ERC. EHD2, the
most divergent of the EHD proteins, controls caveolar mobility and may influence
internalization at the plasma membrane. Used with permission from JCS (Naslavsky
& Caplan, 2018).
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Studies have shown that EHD proteins induce lipid tubulation in vitro (Daumke
et al., 2007), however studies done in cultured cells suggest that the EHD proteins play
an opposite role and promote fission of lipid tubules. Previous studies of the EH domain
and the structure of EHD2 provide evidence that they serve as dynamin-like ATPases in
the fission of endocytic membranes (Cai et al., 2012; Daumke et al., 2007; Jakobsson et al.,
2011; D. W. Lee et al., 2005). In support of EHD1’s function as a fission protein, purified
EHD1 can be added to an ATP-containing semi-permeable system and induce
endosomal fission (Cai et al., 2013). Moreover, recent studies have elucidated the
mechanism by which EHD1 forms oligomers around a tubule and induces fission (Deo
et al., 2018). Additionally, the nuclear magnetic resonance solution structure of the EHD
domain of EHD1 (Kieken, Jovic, Naslavsky, Caplan, & Sorgen, 2007) has led to the
identification of novel interaction partners that contain an asparagine-prolinephenylalanine (NPF) motifs followed by acidic residues that selectively interact with the
positively charged EH domain electrostatic surface area (Henry, Corrigan, Dineen, &
Baleja, 2010).
Our lab discovered MICAL-L1 as a direct interaction partner of the EH domain
of EHD1 (Giridharan et al., 2013; Sharma, Jovic, et al., 2009). The latter binds via the first
of its two NPF motifs, and MICAL-L1 is required for TRE biogenesis and receptor
recycling (Giridharan et al., 2013; Sharma, Jovic, et al., 2009). MICAL-L1 interacts with
many essential regulators of TREs, including Rab8 (Sharma, Jovic, et al., 2009), proteins
that contain a BAR domain (McMahon & Gallop, 2005; Zimmerberg & Kozlov, 2006),
including the N-BAR protein Amphiphysin/Bin1 (Pant et al., 2009), and the F-BAR

33
protein Syndapin2 (or PACSIN2) (Braun et al., 2005; Giridharan et al., 2013). MICAL-L1
and Syndapin2 bind to the PA on the TRE membranes and subsequently recruit EHD1
to the TRE to facilitate fission, giving rise to newly formed endosomes that contain
cargos traveling to and from the ERC.
In addition to the role that EHD1 plays in the recycling of cargos from the PM,
EHD1 interacts with VPS26 and VPS35 and in turn can regulate the retrograde transport
of cargo from EE to the TGN (Gokool et al., 2007). In recent years, the role of EHD1 has
expanded beyond the realm of recycling and it has been revealed as an important player
in mitosis and ciliogenesis (Lu et al., 2015; Reinecke, Katafiasz, Naslavsky, & Caplan,
2015), demonstrating that endocytic regulatory proteins may play a larger role in the cell
than just controlling endocytic trafficking. This notion that endocytic regulatory proteins
can play a role in other pathways, such as EHD1 playing a role in mitosis or ciliogenesis,
has led to us identifying a novel role for EHD1 in mitochondrial fission.
2.4.2 EHD2
EHD2 displays the least amount of homology to EHD1, at only 70% identity. The
structure of EHD2 has been solved and further supports its role in nucleotide-dependent
membrane remodeling (Daumke et al., 2007). EHD2 is involved in the regulation of a
variety of important functions such as sarcolemma repair (Marg, Schoewel), myoblast
fusion (K. R. Doherty et al., 2008; Posey et al., 2011), and controls Rac1 and the actin
cytoskeleton (Benjamin et al., 2011; Stoeber et al., 2012). EHD2 plays a very different role
in regulating endocytic trafficking as compared to the other EHD proteins and is
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recruited to the PM by preferentially binding to phosphatidylinositol (4,5)-bisphosphate
(PI(4,5)P2) (Simone et al., 2013) and is able to regulate caveolar mobility at the PM
(Moren et al., 2012). Previous studies from our lab suggest that the phenylalanine
residue in the EHD2 NPF motif is crucial for its localization to the PM, while the proline
plays a key role in EHD2 dimerization and binding (Bahl, Naslavsky, & Caplan, 2015).
Furthermore, EHD2 is able to bind to the EH-domain-binding protein 1 (EHBP1)
(Guilherme et al., 2004), which implies that there is functional redundancy with EHD1
(M. George et al., 2007), as well as a role for EHD2 with the internalization of TfR and
GLUT4 (Guilherme et al., 2004).
2.4.3 EHD3
EHD3 and EHD1 share the highest percentage of amino acid identity at 86%
(Galperin et al., 2002). However, EHD3 does not seem to play a major role in regulating
the exit of cargos from the ERC back to the PM. Indeed, upon EHD3-depletion, the cargo
accumulates in the EE and does not reach the ERC (Naslavsky et al., 2006). Additionally,
EHD3 is involved in retrograde transport from the EE to the TGN and helps maintain
the morphology of the Golgi membrane (Naslavsky et al., 2009). EHD3 has the capacity
to hetero-dimerize with EHD1 and localizes to the tubulovesicular endosomes (Galperin
et al., 2002). Similar to EHD1, EHD3 binds to Rab effectors, such as Rab11-FIP2,
Rabenosyn-5, and MICAL-L1 (Naslavsky et al., 2006; Sharma, Jovic, et al., 2009). Studies
from our lab have shown that upon knockdown of EHD3, fewer MICAL-L1-decorated
TRE are observed, whereas EHD1-depletion leads to hyper-elongation of TRE. This
finding was further supported by our semi-intact cell system utilizing purified EHD3,
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which led to rapid induction of tubules (Cai et al., 2014). Our lab recently elucidated the
mechanism by which EHD3 supports TRE stabilization, (Bahl et al., 2016)
2.4.4 EHD4
EHD4 localizes primarily to EE and may regulate cargo transport from EE to
both the ERC and the lysosomal degradation pathway (M. George et al., 2007; Sharma et
al., 2008). Studies performed in neuronal cells have shown that EHD4 functions
upstream of EHD1 by regulating the internalization of TrkA and TrkB nerve growth
factor receptors, along with Nogo-A, an inhibitor of axonal growth (Joset, Dodd,
Halegoua, & Schwab, 2010; Shao et al., 2002; Valdez et al., 2005). However, recent
studies in our lab have shown that EHD4 and EHD1 can hetero-dimerize and are
potentially both needed for TRE fission and regulation of cargos back to the PM
(unpublished data).
3. REGULATION OF MITOCHONDRIAL FUSION/FISSION
3.1. Overview
Mitochondria are known for their role in generating ATP via oxidative
phosphorylation but also contribute significantly to many other cellular processes
including but not limited to regulation of reactive oxygen species (Hamanaka &
Chandel, 2010), calcium signaling, (Duchen, 2000; Nicholls, 2005), apoptosis (C. Wang &
Youle, 2009), iron homeostasis (Horowitz & Greenamyre, 2010; Richardson et al., 2010),
and cellular aging (Srivastava, 2017; Sun, Youle, & Finkel, 2016). The functions that are
performed by the mitochondria are closely associated with the regulation of their
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dynamics, which includes continuous rounds of fission and fusion that the mitochondria
depends upon to remain healthy (Chan, 2012). Disruption of the regulation of
mitochondrial fission and fusion may result in many diseases, including Alzheimer’s
disease (Cho et al., 2009) and Parkinson’s disease (PD) (Tang et al., 2015). While there
have been recent advances in the field of mitochondrial homeostasis, many aspects of
the mechanisms that control the dynamics of fission and fusion remain undiscovered.
In order for 2 mitochondria to fuse together, two separate fusion events must
occur, with the first being fusion of the mitochondrial outer membrane (MOM) and the
second being the fusion of the mitochondrial inner membrane (MIM). To date, it is
known that 3 GTPases directly regulate mitochondrial fusion. Mitofusin-1 (Mfn1) and
Mitofusin-2 (Mfn2) are in charge of fusing the MOM, while the MIM is fused together by
optic atrophy 1 (OPA1). The fusion of two mitochondria is critical for maintaining
membrane potential and thus ATP production (H. Chen et al., 2003). Fusion events are
also critical for the proper transfer of mitochondrial proteins and mitochondria DNA
(mtDNA) to newly formed mitochondria (Twig & Shirihai, 2011).
The proteins that are needed for mitochondrial fission are just as crucial as the
fusion proteins. Mitochondria are constantly balancing the amount of fission and fusion
to maintain optimal size and shape. Mitochondrial fission is regulated by a long-known
GTPase fission protein, dynamin-related protein 1 (Drp1) (Smirnova, Griparic, Shurland,
& van der Bliek, 2001). However, it wasn’t until recently that researchers discovered a
role for another GTPase, dynamin-2 (J. E. Lee, Westrate, Wu, Page, & Voeltz, 2016).
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While the GTPases are thought to provide the energy needed for a mitochondria to
undergo fission, the process of mitochondrial fission is more complicated and requires
the use of other organelles, such as the endoplasmic reticulum (ER), which helps initiate
the mitochondrial fission before the GTPases are present. Mitochondrial fission events
are critical for remodeling and rearrangement of mitochondria within the cell or the
need to be transferred to a new cell during mitosis (Pagliuso, Cossart, & Stavru, 2018).
Since mitochondrial fission is an important cellular event, subtle changes in the rate of
fission are enough to influence disease states such as Alzheimer’s disease (Castellani et
al., 2002; Moreira, Cardoso, Santos, & Oliveira, 2006) or cardiomyocyte hypertrophy
(Ago et al., 2010; Pennanen et al., 2014).
3.2 Effectors of fusion
3.2.1 Mitofusin-1 and Mitofusin-2 (Mfn1 and Mfn2)
Mfn1 and Mfn2 perform similar functions in the fusion of the MOM and can
even interchange under certain conditions (H. Chen et al., 2003). While Mfn1 and Mfn2
are interchangeable, mutations in Mfn2 alone can have serious consequences and result
in disease states such as Charcot-Marie-Tooth Neuropathy type 2A (H. Chen, Chomyn,
& Chan, 2005; H. Chen et al., 2003). This suggests that it only takes a minor disturbance
in the balance between fission and fusion to disrupt mitochondrial function and lead to a
disease state. Mfn1 and Mfn2 are MOM transmembrane GTPases that contain several
conserved domains such as an amino-terminal GTP-binding domain, 2 coiled-coil
domains and a carboxyl-terminal with a bipartite transmembrane domain (Chandhok,
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Lazarou, & Neumann, 2017). While Mfn1 and Mfn2 do play similar roles and have
structural homology, Mfn2 has an N-terminal Ras-binding domain that is lacking in
Mfn1, suggesting that Mfn2 might have specificity towards a cellular pathway that Mfn1
does not have (K. H. Chen et al., 2004). The second coiled-coil domain of Mfn1 or Mfn2
is responsible for the tethering of the opposing mitochondria through dimerization of
anti-parallel coiled-coiled domains, forming either homotypic or heterotypic dimers
(Koshiba et al., 2004). Understanding the precise mechanism of signaling that allows
Mfn1 or Mfn2 to join two adjacent mitochondria is under active research. (Figure 1.6).
3.2.2 Optic atrophy protein 1 (OPA1)
OPA1 is the major protein that is responsible for the fusion of the MIM and is also
thought to be involved in proper cristae folding as well as potentially playing a role in
apoptosis (Griparic, van der Wel, Orozco, Peters, & van der Bliek, 2004; Ni, Williams, &
Ding, 2015). Interestingly, OPA1 requires the presence of Mfn1 but not Mfn2 to be
functional (Cipolat, Martins de Brito, Dal Zilio, & Scorrano, 2004). The loss of OPA1
function can lead to dominant atrophy, an inherited disease that culminates in the
degeneration of the optic nerve, suggesting that OPA1 may be important in
mitochondrial fusion and homeostasis (H. Chen & Chan, 2005, 2009). For OPA1 to
become fully functional, it must be transported to the mitochondria and undergo
proteolytic cleavage into 2 separate isotypes, known as long and short forms (Ishihara,
Fujita, Oka, & Mihara, 2006). The concentrations of the 2 isotypes under normal
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Figure 1.6
Mitochondrial fusion. Mitochondrial fusion via homotypic and heterotypic
mitofusin interactions mediates OMM fusion, while OPA1 is responsible for IMM
fusion events. Used with permission from Traffic (Farmer et al., 2018).
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conditions are nearly equal and must remain that way for fusion of the MIM (Liesa,
Palacin, & Zorzano, 2009). The long and short isotypes cannot work separately to
complete MIM fusion but must work in tandem to successfully fuse two mitochondria
(Song, Chen, Fiket, Alexander, & Chan, 2007) (Figure 1.6).
3.3 Effectors of fission
3.3.1 ER/mitochondria contact sites
Previous studies have shown that the ER and the mitochondria share contact
sites that are essential for phospholipid synthesis, calcium signaling, and marking
constriction sites on the mitochondria, indicating where fission needs to occur (de Brito
& Scorrano, 2010; Friedman et al., 2011). There are several types of connections or
bridges that can be made between the ER and the mitochondria. For example, a distinct
structure termed the ER mitochondria encounter structure (ERMES) can be found in
yeast and is involved in mitochondrial fission, while in mammalian cells, the fusion
protein, Mfn2, is potentially responsible for tethering the ER and mitochondria together
(de Brito & Scorrano, 2008; Kornmann et al., 2009). More recent studies have been able to
identify PDZ domain containing 8 (PDZD8), a homolog of the yeast ERMES protein
maintenance of mitochondrial morphology protein (MMM1), as playing a crucial role in
tethering mitochondria to the ER in mammalian neurons (Hirabayashi et al., 2017). It is
interesting to note that even with mitochondria remaining dynamic under physiological
conditions, the ER contact sites seem to be very stable, suggesting their presence is
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constantly needed for mitochondrial homeostasis (Friedman, Webster, Mastronarde,
Verhey, & Voeltz, 2010).
It is thought that the ER plays a role in the initial constriction of the
mitochondria, to promote fission (Friedman et al., 2011; Korobova, Ramabhadran, &
Higgs, 2013). Indeed, it has been demonstrated that the ER-localized inverted formin 2
protein is able to induce actin polymerization between the ER and mitochondria, which
is the driver for initial mitochondrial fission (Korobova et al., 2013). The initial
constriction done by the ER is critical to facilitate a proper fission event as Drp1
oligomers are unable to wrap around a non-constricted mitochondria. Mitochondria
typically have a diameter around 200 nm or more and based on their size, Drp1
oligomers can form around structures that have a maximal diameter of 110 to 130 nm
(Friedman et al., 2011). Consistent with this data, ER constriction sites have been known
to constrict the mitochondria down to around 140 nm in diameter, suggesting that the
ER must first constrict the mitochondria to allow Drp1 oligomers to further constrict
(Friedman et al., 2011) (Figure 1.7).
3.3.2 Dynamin-related protein 1 (Drp1)
Under normal conditions, Drp1 is mainly a cytosolic protein that is recruited to
the mitochondria upon initial constriction by the ER. Drp1 is part of the dynamin family
of GTPase proteins but unlike its isoform, dynamin-2, Drp1 lacks a lipid-binding
pleckstrin homology domain; therefore it is unable to bind directly to the mitochondrial
membrane (Mears et al., 2011; Pagliuso et al., 2018). To make up for the lack of binding,
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Drp1 must bind to receptors that are found on the mitochondrial membrane. In
mammalian cells, many Drp1 receptors located on the MOM have been identified, such
as mitochondrial fission 1 protein (Fis1), mitochondrial fission factor (Mff), or
mitochondrial dynamics protein 49 and 51 (MiD49/MiD51) (Loson, Song, Chen, & Chan,
2013; Otera et al., 2010; Palmer et al., 2013; Palmer et al., 2011; Zhao et al., 2011). While
all of the receptors can recruit and bind Drp1 to the mitochondrial membrane, studies
suggest that Mff is the most prominent receptor for mitochondrial fission (Loson et al.,
2013). Once Drp1 is recruited to the MOM, oligomers form around the ER and Drp1 uses
GTP hydrolysis to further constrict the mitochondria. However, it is important to note
that Drp1 is unable to complete the fission process and therefore needs an additional
fission factor (Frohlich et al., 2013). (Figure 1.7).
3.3.3 Dynamin-2 (Dyn2)
As previously mentioned, the role of Dyn2 has been well-established in the
fission of clathrin-coated vesicles at the plasma membrane during endocytosis
(Gonzalez-Jamett et al., 2013). Similar to Drp1, Dyn2 is able to form oligomers around a
membrane and use its GTPase function to complete a fission event (Ferguson & De
Camilli, 2012). Until recently, the model for mitochondrial fission proposed that after the
initial constriction of the mitochondria by the ER, Drp1 was able to further constrict the
mitochondria until a single mitochondria splits into two separate structures. However,
new evidence now supports the model that Dyn2 not only acts at the plasma membrane
but also plays a key role in the later stages of mitochondrial fission, following
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Figure 1.7
Mitochondrial fission. Constriction of the mitochondrial membrane is first initiated
by the ER at ER/mitochondria contact sites. After constriction by the ER, the
mitochondrial membrane is “marked” for fission, thus resulting in Drp1 recruitment
by Drp1 receptors. Drp1 then forms oligomers around the constriction site and
further constricts the membrane through GTPase activity, leading to Dyn2/Dnm2
recruitment, additional GTP hydrolysis, and completion of the process of fission
resulting in 2 separate mitochondria. Used with permission from Traffic (Farmer et
al., 2018).
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constriction by the ER and Drp1 (J. E. Lee et al., 2016). It has been shown that Drp1 and
Dyn2 must both be present for mitochondrial fission to occur. Loss of either protein
leads to elongated mitochondria due to a lack of fission (J. E. Lee et al., 2016). The
studies performed by Lee et al. highlight the growing appreciation for the role of
endocytic regulatory proteins in mitochondrial homeostasis. (Figure 1.7)
3.4 Other modes of regulating mitochondrial fusion and fission
Traditionally, it is thought that mitochondrial homeostasis is regulated by the
GTPases, Mfn1, Mfn2, OPA1, Drp1 and its MOM receptors, and more recently, Dyn2.
However, recent mitochondrial homeostasis research has demonstrated that the
regulation of mitochondria is far more complex than previously thought. Studies are
starting to show how important the upstream events that involve the trafficking and
regulation of the mitochondria-associated proteins, thus providing additional
mechanisms of indirect mitochondrial fission and fusion.
One key protein that indirectly regulates mitochondrial homeostasis through the
trafficking of mitochondrial-associate fusion or fission proteins is vacuolar protein
sorting 35 (VPS35) (Tang et al., 2015; W. Wang, Ma, Zhou, Liu, & Zhu, 2017; W. Wang et
al., 2016). VPS35 is a subunit of a larger complex termed retromer cargo selective
complex (CSC). The retromer CSC is comprised of 3 vacuolar protein sorting proteins,
VPS26, VPS29, and VPS35, and associates with sorting nexin proteins (SNX) (Seaman,
2004). The original function described for the retromer CSC was retrieval of the
mannose-6 phosphate receptor (M6PR) from peripheral endosomes back to the trans-
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Golgi network (TGN) (Arighi, Hartnell, Aguilar, Haft, & Bonifacino, 2004). Later on,
other cargo was found to be regulated by the retromer, including the iron transporter
DMT1‐11/Slc11a2 (Tabuchi, Yanatori, Kawai, & Kishi, 2010), the Wnt transport protein
Wntless/MIG‐14 (Eaton, 2008), and others. Exciting new studies have implicated a role
for VPS35 in mitochondrial fusion and fission as they relate to PD (Tang et al., 2015; W.
Wang et al., 2017; W. Wang et al., 2016). While VPS35 has been associated with
mitochondrial homeostasis and PD, the mechanisms by which VPS35 regulates
mitochondrial morphology remains controversial and unclear.
3.4.1. Indirect role of VPS35 in mitochondrial fusion
The proteins associated with regulating the fusion of mitochondria, Mfn1, Mfn2,
and OPA1, are regulated by post-translational modifications, with one key type of
modification being ubiquitination. The ubiquitination of Mfn2 targets the fusion protein
for degradation by the proteasome, thus limiting the amount of fusion that can take
place. Recent studies have demonstrated a role for VPS35 in regulating the
ubiquitination of Mfn2, most likely by trafficking of the E3 ubiquitin ligase, MUL1,
which is responsible for ubiquitinating Mfn2 on the mitochondria membrane (Tang et
al., 2015). Tang et al showed that VPS35-depletion induces a PD-like condition that
causes fragmented mitochondria and cell death in mouse dopamine neurons (Tang et
al., 2015). Under these experimental conditions, VPS35 interacts with MUL1 and
sequesters it in the cytoplasm but under VPS35-depletion conditions, the MUL1 is free to
traffic to the mitochondria where it ubiquitinates Mfn2 and induces the degradation of
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Mfn2, leading to reduced mitochondrial fusion and fragmented mitochondria. (Top
portion of Figure 1.8)
3.4.2. Indirect role of VPS35 in mitochondrial fission
While the previously mentioned study suggests a role for VPS35 in the
regulation of mitochondrial fusion, a recent study provides experimental evidence that
supports a role for VPS35 in the regulation of mitochondrial homeostasis. Wang et al.
demonstrated that VPS35 binds to complexes of inactive mitochondrial fission proteins,
Drp1, on the mitochondrial membrane. It is proposed that upon binding of VPS35 and
inactive Drp1 on the mitochondrial membrane, mitochondrial-derived vesicles (MDVs)
are generated and therefore remove the inactive Drp1 for transport to the lysosome for
degradation (W. Wang et al., 2017; W. Wang et al., 2016). As a result, this frees Drp1
receptors at mitochondrial constriction sites to recruit and/or activate Drp1 and promote
mitochondrial fission (W. Wang et al., 2017; W. Wang et al., 2016). The MDVs generated
in this model consist of structures with diameters of 70 to 150 nm (Cadete et al., 2016)
and are considered to be important for quality control mechanisms that deliver
mitochondria-related proteins and membranes to the late endosomes or multivesicular
bodies (Soubannier, McLelland, et al., 2012). While the exact mechanism of how the
cargo for the MDVs is selected at the mitochondria is unknown, studies have shown that
both MIM and MOM membranes can be used to generate MDV and contain both
membrane bound and mitochondrial matrix proteins (McLelland, Soubannier, Chen,
McBride, & Fon, 2014; Neuspiel et al., 2008; Soubannier, McLelland, et al., 2012;
Soubannier, Rippstein, Kaufman, Shoubridge, & McBride, 2012). It is important to note
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that a mutated form of VPS35 that is commonly found in PD, VPS35D620N, causes
extensive mitochondrial fragmentation and loss of function, providing additional
evidence that VPS35 plays a critical part in PD related dysfunction. (Bottom portion of
Figure 1.8).
4. REGULATION OF MITOCHONDRIA INDUCED APOPTOSIS
4.1 Overview
Apoptosis is an essential cellular event that is required for normal development
and maintenance of whole tissue homeostasis, protection from genomic miscues, and to
control humoral immune responses (Slomp & Peperzak, 2018). During the process of
apoptosis, a cell will begin to shrink, fragment its DNA, and eventually break up into
smaller apoptotic bodies that can easily be cleared by phagocytes (Fadeel & Orrenius,
2005). The process of apoptosis results in activation of cysteine proteases termed
caspases that cleave cellular proteins that are critical for survival. These caspases are
activated through either an extrinsic apoptosis pathway, which becomes active when the
death receptor, located on the surface of the target cell, becomes engaged. Caspases can
also be activated by the intrinsic pathway that is initiated by internal cellular stresses.
Apoptosis is a highly regulated process, making it impossible to expand on every aspect
of both the extrinsic and intrinsic pathways. Due to this, I will focus primarily on the
intrinsic pathway of apoptosis, in particular, the regulation of the intrinsic pathway by
the B-cell lymphoma 2 (Bcl-2) family of proteins. For more detailed information on the
extrinsic and intrinsic pathway, refer to the review by Elmore (Elmore, 2007).
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Figure 1.8
Potential roles of VPS35 in mitochondrial fission/fusion. Model representing the
role of VPS35 (pink) in mitochondrial fission (bottom left) or mitochondrial fusion
(top right). For fission, VPS35 removes inactive Drp1 (red) and traffics it to the
lysosome for degradation, to allow active Drp1 (green) to further constrict the OMM.
For fusion, VPS35 regulates MUL1 (orange) localization to the OMM, where it binds to
Mfn2 (red) and induces its polyubiquitination (yellow) to target it for proteasomal
degradation. Used with permission from Traffic (Farmer et al., 2018).
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4.2 Bcl-2 protein family regulation
The Bcl-2 family of proteins is a key group of regulators that controls apoptosis
by regulating the mitochondrial outer membrane permeabilization MOMP. Once
MOMP occurs, cytochrome c is released and activates the caspases that carry out the rest
of the apoptotic process. The Bcl-2 family can be divided into 3 main groups depending
on the function that they serve in either preventing or promoting mitochondria induced
apoptosis (1) anti-apoptotic proteins (Bcl-2, Bcl-xL, Bcl-W, Mcl-1, Bfl-1/A1), (2) proapoptotic pore-formers (Bax, Bak) and (3) pro-apoptotic BH3-only proteins (BAD, BID,
BIK, BIM, BMF, HRK, NOXA, PUMA, etc.) (Kale, Osterlund, & Andrews, 2018). All of
the Bcl-2 family members contain a BH3 domain, which is one of the four BH domains
that help facilitate the interactions between family members (Lomonosova &
Chinnadurai, 2008). Members of the anti-apoptotic and pro-apoptotic groups contain all
4 of the BH domains and therefor have a highly conserved structure that forms a
hydrophobic BH3 domain-binding groove (Shamas-Din, Brahmbhatt, Leber, &
Andrews, 2011). In addition to the BH domains, most of the Bcl-2 family members have
a transmembrane domain (TD) that allows them to localize to various membranes, such
as the mitochondria or ER. The Bcl-2 family members who do not have the TD interact
with other proteins on the membranes. The ability of different Bcl-2 proteins to interact
with each other is critical for regulation of MOMPs. When the interactions favor the pore
formation of Bax/Bak on the MOM, cytochrome c is released from the mitochondria and
the intrinsic pathway is activated (Wei et al., 2001). BH3-only proteins play a role as cell
death initiators whose activity is transcriptionally or post-translationally regulated
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depending on the upstream cell signaling (Czabotar, Lessene, Strasser, & Adams, 2014;
Danial & Korsmeyer, 2004; Youle & Strasser, 2008). (Figure 1.9)
There are various competing models for how the interactions between Bcl-2
family members interact to either prevent or promote apoptosis. However, in all models,
the BH3 domain is a necessary component for the primary apoptotic function of Bcl-2
family members and mediates the interactions between them. For example, the BH3
domain of the BH3-only activator proteins can bind to the BH3 domain-binding groove
of the Bax or Bak and activate them to induce mitochondria pore formation and
apoptosis (Czabotar et al., 2013; Moldoveanu et al., 2013). Upon binding of the BH3-only
activator to Bax or Bak, a series of conformational changes occurs that allows for the Bax
or Bak to be homo-oligomerized and form the pore in the MOM (Kale et al., 2018). On
the other hand, the BH3 domain-binding groove of the anti-apoptotic proteins can bind
to the BH3 domains of Bax and Bak, along with the BH3-only activator proteins and thus
inhibit their function by sequestering the pro-apoptotic proteins and thus preventing
MOM pore formation (Ku, Liang, Jung, & Oh, 2011; Liu et al., 2010). The BH3-only
sensitizer proteins can bind also bind to the BH3 domain-binding groove of the antiapoptotic proteins and inhibit them from sequestering the pro-apoptotic proteins,
resulting in an increase in the pore formation in the MOM (Petros et al., 2000). For the
most part these interactions occur at or in the MOM and the lipid composition of the
membrane plays a key role in facilitating structural changes of the Bcl-2 family of
proteins and the structure of the protein dictates the binding affinity between family
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members, thus controlling whether pores will be formed or not (Chi, Kale, Leber, &
Andrews, 2014; Shamas-Din et al., 2013). (Figure 1.9)
5. SUMMARY AND CONCLUSIONS
Endocytic trafficking is a highly regulated and important process for overall
cellular health. There have been major advances in understanding how the proteins that
regulate this pathway interact, sort, and traffic internalized cargo from the PM over the
last two decades. Along with determining the mechanisms by which they regulate
trafficking, there is a growing body of work showing a relationship between endocytic
regulatory proteins and other organelles, such as centrosomes, cilia, and mitochondria.
For example, the role of the GTPase Dyn2 in both endocytic fission at the PM and in
mitochondrial fission has been highlighted recently as well as the novel role for the
retromer complex in regulating the trafficking of Drp1. The newly discovered function
of the retromer has solidified the links between endocytic pathways and mitochondria.
However, it remains unknown whether other proteins that interact with the retromer
also play a role in the regulation of mitochondrial fusion or fission. Chapter II will
highlight a novel role for the retromer interaction partners, EHD1 and Rabankyrin-5, in
indirectly regulating mitochondrial fission through control of the retromer localization.
Mitochondria play many roles within the cell to help maintain overall
homeostasis, such as reactive oxygen regulation, calcium signaling, apoptosis, iron
homeostasis, and cellular aging. With the growing body of work supporting the idea
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Figure 1.9
BCL-2 family interactions and regulation of BAX/BAK oligomerization. BAX/BAK
activation is directly triggered by activator BH3-only proteins (BIM, BID and PUMA)
and is inhibited by anti-apoptotic BCL-2 family members. Sensitizer BH3-only
proteins do not activate BAX and BAK directly, but lower the threshold for apoptosis
by binding anti-apoptotic members and releasing activators to trigger BAX and BAK
oligomerization. Anti-apoptotic BCL-2 proteins inhibit activator BH3-only proteins
and BAX/BAK oligomerization. Used with permission from Trends in Endocrinology
and Metabolism (Gimenez-Cassina & Danial, 2015).
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that endocytic regulatory proteins play a key role in regulating the fusion and fission of
mitochondria, it raises the question whether they also play a role in other mitochondrial
functions. All of these functions are extremely important for cellular health but the role
that mitochondria play in apoptosis might be the most important. Apoptosis induced by
permeabilization of the mitochondrial membrane is regulated by the Bcl-2 family of
proteins. Some of these proteins can be found on the mitochondrial membrane, while
others, such as Bax or Bcl-xL, must traffic to the mitochondria to either form pores or
prevent pore formation,. Studies have shown that Bax most likely undergoes simple
diffusion to reach the mitochondrial membrane. However, to date there is no available
data to explain how Bcl-xL traffics to the mitochondria to prevent pore formation.
Although Bcl-xL may undergo simple diffusion, given how highly regulated apoptosis
is, it is logical to think there is something regulating this translocation from the
cytoplasm to the mitochondria. Chapter III will describe, for the first time, a relationship
between endocytic regulatory proteins and Bcl-xL. In this chapter I propose a model for
how the retromer is able to regulate the translocation of Bcl-xL to the mitochondrial
membrane, and I demonstrate that without the retromer, the rate of apoptosis is
enhanced.
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Chapter II

ROLE OF ENDOCYTIC REGULATORY PROTEINS IN MITOCHONDRIAL
HOMEOSTASIS

With permission from Journal of Cell Science, parts of this chapter were derived from:
(Farmer et al., 2017)

Farmer, T., J.B. Reinecke, S. Xie, K. Bahl, N. Naslavsky, and S. Caplan. 2017. Control of
mitochondrial homeostasis by endocytic regulatory proteins. J Cell Sci.
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6. ABSTRACT
Mitochondria play crucial roles in producing cellular energy, regulating reactive
oxygen species (ROS), and controlling apoptosis. Mitochondrial function is regulated by
constant fusion and fission but the mechanisms that maintain mitochondrial
homeostasis remain incompletely understood. Recent studies implicate Dyn2 and Drp1
as two GTPases that are required for regulating mitochondrial fission. In Chapter II, we
demonstrate that the ATPase and endocytic protein, EHD1, is a novel regulator of
mitochondrial fission. Depletion of EHD1 results in static and elongated networks of
mitochondria, similar to that observed upon Dyn2- or Drp1-depletion. However,
depletion of Dyn2 or Drp1 interferes with the susceptibility of cells to staurosporineinduced mitochondrial fragmentation, whereas EHD1-depleted cells remain sensitive to
staurosporine (STS), suggesting that EHD1 functions through a different mechanism
than the two GTPases. Recent studies have demonstrated that VPS35 and the retromer
complex influence mitochondrial morphology by one of two mechanisms: 1) Decreased
fusion by Mul1-mediated ubiquitination and degradation of fusion protein Mfn2, or 2)
Increased fission by removing inactive Drp1 from the mitochondrial membrane. Herein,
we provide evidence that EHD1 and its interaction partner, Rabankyrin-5, interact with
the retromer complex to influence mitochondrial dynamics, likely by inducing VPS35 to
remove inactive Drp1 from the mitochondrial membrane. Chapter II sheds light on
mitochondrial homeostasis, expanding on novel concepts pertaining to endocytic
regulatory proteins and their impact on mitochondrial dynamics.
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7. INTRODUCTION
Mitochondria play an essential role in the overall homeostasis of a cell. Among
their many functions are the regulation of ATP levels via oxidative phosphorylation,
Ca2+ signaling (Duchen, 2000; Nicholls, 2005), apoptosis (C. Wang & Youle, 2009), and
ROS generation and sequestration (Hamanaka & Chandel, 2010). The function of the
mitochondria is closely controlled by their dynamics, and they are continually
undergoing rounds of fusion and fission, a process required for mitochondrial health
and homeostasis (Chan, 2012). Indeed, small disruptions in the dynamics of
mitochondria can result in a wide variety of diseases, such as Alzheimer’s disease (Cho
et al., 2009) and PD (Tang et al., 2015). The mechanisms by which mitochondrial
dynamics influence these neurological disorders remain unclear. However, fusion and
fission control mitochondrial size and shape, the total number of mitochondria, and
many mitochondrial functions such as respiration and cell survival (Chan, 2012; Flippo
& Strack, 2017). Despite the significance of mitochondrial dynamics and the growing
number of molecules involved in these events, many of the mechanisms regulating
mitochondrial dynamics remain unknown.
For mitochondria to undergo fusion, there need to be two distinct fusion events,
between both the outer membranes and inner membranes of apposing mitochondria.
Three mammalian GTPases have been implicated in regulating mitochondrial fusion: the
mitofusins Mfn1 and Mfn2 control fusion of the MOM (Rojo, Legros, Chateau, &
Lombes, 2002; Santel & Fuller, 2001) and OPA1 mediates fusion of the MIM (Alexander
et al., 2000; Delettre et al., 2000). The dynamin-related GTPase Drp1 has been identified
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as a key protein required for mitochondrial fission (Bleazard et al., 1999; Labrousse,
Zappaterra, Rube, & van der Bliek, 1999). Mitochondrial membrane receptors recruit
Drp1 to the MOM, where it functions in constriction, and the absence of Drp1 from the
cell leads to elongated mitochondrial networks. In addition to Drp1, a recent study
demonstrated that Dyn2 coordinates with Drp1 to sequentially mediate the final step of
mitochondrial fission (J. E. Lee et al., 2016).
While identification of proteins that play a direct role in mitochondrial
homeostasis and the elucidation of their mechanisms of action has expanded rapidly in
recent years, less is known about the indirect regulation of mitochondrial fusion and
fission. One new enticing area of research relates to recent studies pointing to a novel
role for endocytic regulatory proteins in controlling mitochondrial fusion and fission.
For example, VPS35, a component of the retromer cargo selection complex that initially
was described as being responsible for regulating the trafficking of cargos from
endosomes to the Golgi (Arighi et al., 2004), is a key regulator of mitochondrial
dynamics and one of only a handful of proteins that cause familial PD (Kumar et al.,
2012; Vilarino-Guell et al., 2011; Zimprich et al., 2011). Indeed, suppression of VPS35 in
hippocampal neurons results in degeneration, abnormal dendritic spines, and swollen
axons (C. L. Wang et al., 2012), and overall VPS35 expression is decreased in PD patients
(MacLeod et al., 2013).
The mechanisms by which VPS35 and the retromer control mitochondrial
homeostasis are not well understood. A recent study has shown that a reduction in the
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protein level of VPS35 in mouse dopamine neurons induces a PD-like phenotype that
includes neuronal death, α-synuclein deposition and fragmented mitochondria (Tang et
al., 2015). In the same study, it was shown that VPS35 depletion or mutation led to
upregulation of Mul1, an ubiquitin ligase that ubiquitinates Mfn2 and inducing the
degradation of Mfn2 through the proteasome, and may result in more fission than
fusion, and thus fragmented mitochondria (Tang et al., 2015). On the other hand, a
second study provides support for a model that suggests VPS35 binds to Drp1 on the
mitochondrial membrane and facilitates the removal of inactive Drp1 and transports it
to the lysosome for degradation, allowing active Drp1 to bind to free receptors on the
mitochondria to promote constriction and eventually fission (W. Wang et al., 2017; W.
Wang et al., 2016).
In Chapter II, we demonstrate that the endocytic fission protein and ATPase,
EHD1, is a novel player in regulating mitochondrial dynamics and homeostasis. The
depletion of EHD1 from cultured cells results in an elongated network of mitochondria
that becomes highly static compared to normal mitochondria. While EHD1 has
considerable homology to the dynamin family members Drp1 and Dyn2, EHD1
knockdown is unable to prevent STS-induced mitochondrial fragmentation, unlike the
knockdown of Drp1 and Dyn2. This suggests that EHD1 does not play a role alongside
Drp1 and Dyn2 and more likely functions in a regulatory capacity. Previous work in the
lab has shown that EHD1 and its binding partner Rabankyrin-5 both interact with the
retromer complex, and we now hypothesize that EHD1 regulates mitochondrial fission
through its control of VPS35 localization within the cell. My findings support a
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mechanism by which EHD1 and Rabankyrin-5 interact with the retromer and influence
mitochondrial homeostasis by controlling VPS35-mediated removal of inactive Drp1
from the mitochondrial membrane.
8. MATERIALS AND METHODS
8.1 Reagents and antibodies
Mitotracker Red was purchased from Thermo Fisher Scientific (M7512). STS was
purchased from Sigma-Aldrich (S5921). Antibodies against the following proteins were
used: EHD1 (ab109311, 1:1000 dilution for immunoblotting), Vps26 (ab23892, 1:500
dilution for immunoblotting), VPS35 (ab97545, 1:500 dilution for immunoblotting), Mfn2
(ab56889, 1:500 dilution for immunoblotting) and actin (ab14128, 1:4000 dilution for
immunoblotting) from Abcam; Tom20 (sc-11415, Santa Cruz Biotechnology, 1:1000
dilution for immunofluorescence); Mul1 (GTX112673, GeneTex, 1:500 dilution for
immunoblotting); GST conjugated to horseradish peroxidase (HRP) (NA935, Amersham,
1:5000 dilution for immunoblotting); MICAL-L1 (H00085377-B01P, Abnova, 1:500
dilution for immunoblotting); Rabankyrin-5 (PA5-24640, Thermo Scientific, 1:200
dilution for immunoblotting); Drp1 (8570s, Cell Signaling, 1:500 dilution for
immunoblotting); GM130 (610822, BD Biosciences, 1:500 dilution for immunoblotting);
donkey anti-mouse IgG light chain conjugated to HRP (715-035-151, 1:10,000 dilution for
immunoblotting), mouse anti-rabbit IgG light chain conjugated to HRP (211-032-171,
1:10,000 dilution for immunoblotting), from Jackson; and donkey anti-mouse-IgG
conjugated to Alexa Fluor 488 (A21202, 1:700 dilution for immunofluorescence), donkey

60
anti-mouse-IgG conjugated to Alexa Fluor 568 (21043, 1:700 dilution for
immunofluorescence), goat anti-rabbit-IgG Alexa Fluor 488 (A11034, 1:700 dilution for
immunofluorescence), and goat anti-rabbit-IgG conjugated to Alexa Fluor 568 (A11036,
1:700 dilution for immunofluorescence) from Molecular Probes.
8.2 Cell Culture
The HeLa cervical cancer cell line was purchased from American type Culture
Collection (ATCC) and grown in DMEM with high glucose containing 10% fetal bovine
serum (FBS), 1x penicillin-streptomycin (Invitrogen, 10378016), and 2mM glutamine. The
immortalized retinal pigment epithelium (RPE) cell line was obtained from ATCC and
grown in DMEM/F12 containing 10% FBS, 1× penicillin-streptomycin and 2 mM
glutamine. Cell lines were routinely tested for mycoplasma contamination.
8.3 siRNA transfection and rescue experiments
Custom EHD1 siRNA oligonucleotides (described in (Sharma, Giridharan,
Rahajeng, Naslavsky, & Caplan, 2009)), and On-Target Rabankyrin-5 siRNA
oligonucleotides were purchased from Dharmacon. RPE cells were transfected using
Liptofectamine RNAiMax (Invitrogen) with 40nM oligonucleotide. The efficiency of the
knockdown was measured by immunoblotting or immunofluorescence at 72 h post
transfection for each experiment. For rescue experiments, RPE cells were simultaneously
treated for EHD1 siRNA and transfected using Fugene 6 (Roche) with a GFP-myc-EHD1
construct engineered with silent mutations making it resistant to the siRNA
oligonucleotides.

61
8.4 Recombinant gene expression and protein purification
The recombinant DNA constructs (GST-EHD1 and GST-EH1) were expressed in
E. coli Rosetta (R2) cell strain and purified by affinity chromatography. Briefly, a freshly
transformed colony of E. coli was inoculated in 50 ml of Luria-Bertani (LB) broth (with
100 µg/ml of ampicillin) and cultured overnight at 37°C with continuous shaking
(primary culture). Next, the primary culture was inoculated in 1000 ml of fresh LB broth
in a 1:100 dilution and incubated at 37°C with continuous shaking until the OD was
within 0.4-0.6 at 600 nm. The culture was then induced with 1 mM IPTG overnight at
18°C. The cells were then centrifuged at 2100 x g for 15 min at 4°C. The bacterial pellet
obtained was re-suspended in ice-cold lysis buffer (1 x PBS, pH 7.4) containing 1
tablet/10 ml protease inhibitor cocktail (Roche). Sample lysis was performed by six
cycles of sonication on ice (2 min bursts/2 min cooling/200-200 watts in a Branson
Sonicator, USA). The lysate was centrifuged at 18000 x g for 30 min at 4°C, which
allowed separation of clear supernatant and cellular debris. The supernatant was then
mixed and allowed to bind with glutathione sepharose resin for 4 h at 4°C. The beads
were then washed two times with 2 x PBS, followed by one time with 1 x PBS. The GSTtagged proteins then underwent elution for 4 h at 4°C in elution buffer containing 300
mM Imidazole, 50 mM Tris and 200 mM NaCl, pH 8.0, and 30 mM glutathione (reduced)
in 50mM Tris-HCl, pH 8.0 followed by centrifugation at 2100 x g for 5 min at 4°C. The
purified proteins were then dialyzed against dialysis buffer (50 mM Tris pH 8.0, 200 mM
NaCl, and 100 mM PMSF) overnight at 4°C.
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8.5 Co-immunoprecipitation and GST pulldown
HeLa cells were grown in 100mm dishes until confluent. Cells were lysed using
buffer containing 50 mM Tris, pH 7.4, 100 mM NaCl, 0.5% Triton X-100, and 1x protease
cocktail inhibitor (Millipore) (lysis buffer) on ice for 30 min. Lysates were incubated with
either anti-Mul1 at 4°C overnight. Protein G beads (GE Healthcare) were added to the
lysate-antibody mix at 4°C for 4 h. Samples were then washed 3 times with the same
buffer used to lyse the cells. Proteins were eluted from the protein G beads by boiling in
the presence of 4x loading buffer (250 mM Tris, pH 6.8, 8% SDS, 40% glycerol, 5% βmercaptoethanol, 0.2% bromophenol blue) for 10 min. Eluted proteins were then
identified by immunoblotting (described below).
For GST pulldowns, 50 µg of purified GST fusion proteins, EHD1 and EH1, were
incubated with GST beads in lysis buffer and incubated at 4°C for 4 h. The GST beads
were then washed three times with the lysis buffer. The GST beads were then added to
bovine brain cytosol at 4°C overnight. Samples were then washed three times with lysis
buffer. Proteins were eluted from the GST beads by boiling in the presence of 4x loading
buffer (250 mM Tris, pH 6.8, 8% SDS, 40% glycerol, 5% β-mercaptoethanol, 0.2%
bromophenol blue) for 10 min. Eluted proteins were then identified by immunoblotting
(described below).
8.6 Immunoblotting
Cells, HeLa or RPE, were washed twice in ice-cold phosphate-buffered saline
(PBS) and then scraped off plates with a rubber policeman into ice-cold lysis buffer (50
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mM Tris-HCl pH 7.4, 100 mM NaCl, 0.5% Triton X-100 and 1x protease cocktail
inhibitor). Protein levels of post-nuclear lysates were quantified by using the Bradford
assay for equal protein level loading. For immunoblotting, 20–30 μg of protein per lysate
were separated by 10% SDS-PAGE. Proteins within the gel were transferred onto
nitrocellulose membranes and blocked for 30 min at room temperature in PBS with 0.3%
Tween 20 (PBST) and 5% non-fat dry milk. The membranes were then incubated with
the appropriate primary antibodies diluted in PBST. Membranes were then washed in
PBST three times for 5 min and then incubated with the appropriate secondary antibody
diluted in PBST for 30 min.
8.7 Quantification of immunoblots
The adjusted relative density of the immunoblots was measured in ImageJ
according to the following protocol:
http://www1.med.umn.edu/starrlab_deleteme/prod/groups/med/@pub/@med/@starrlab/
documents/content/med_content_370494.html.
8.8 Quantification of mitochondrial parameters
The average size, perimeter, and circularity of mitochondria were measured in
ImageJ, using a plugin called Mito Morphology Macro
(http://imagejdocu.tudor.lu/doku.php?id=plugin:morphology:mitochondrial_morpholog
y_macro_plug-in:start). Images of Tom20-stained cells were imported into ImageJ where
the program was able to set a common threshold and calculate the mitochondrial
parameters.
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8.9 Quantification of VPS35 subcellular distribution
The distribution of VPS35-positive vesicles was assessed using ImageJ. Multichannel images were split into individual channels. An area was drawn around the
Golgi region, marked with a Golgi marker GM130, using the ‘free hand’ tool. The region
of interest was then superimposed on the image of the VPS35 immunostaining and the
mean VPS35 fluorescence intensity of that region was measured and calculated.
8.10 Immunofluorescence
RPE cells were treated as described in the chapter and then fixed in 4%
paraformaldehyde in PBS for 10 min at room temperature. Cells were then rinsed three
times with PBS and then incubated with the appropriate primary antibody diluted in
PBS containing 0.5% BSA and 0.2% saponin (staining buffer) for 1 h at room
temperature. The cells were then washed three time and incubated with the appropriate
secondary antibody diluted in staining buffer for 30 min at room temperature. Upon
completion, the cells were washed three times with PBS and mounted on a microscope
slide with Fluoromount.
Using a Zeiss LSM800 confocal microscope with a 63×1.4 NA oil objective, zstack confocal images were collected. The series of images from a z-stack was then
processed to yield a maximal projection image using the Zeiss Zen software. For
quantification, collected maximal projection images were imported into ImageJ as
described above.
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8.11 Live imaging
RPE cells were plated on 35mm glass-bottom dishes and transfected with the
appropriate siRNA treatment. At 72 h post transfection, the cells were treated with 25
nM Mitotracker Red for 15 min in Opti-mem media lacking antibiotics. The cells were
then washed three times with DMEM/F12 containing no Phenol Red. After the last wash,
DMEM/F12 with no Phenol Red was added to the dish, along with 10% FBS.
Using the system described above, a four slice z-stack image was taken every 15 s
for 5 min for each treatment. Each z-stack was then converted into a maximal projection
image as described above and quantification was performed.
8.12 STS assay
RPE cells were treated with 1 μM STS (Sigma Aldrich) for the last 1 h of a 72 h
siRNA transfection. The cells then underwent processing for immunofluorescence as
described above.
8.13 Statistics
Data from ImageJ was imported in Microsoft Excel where means and standard
deviations were calculated from the data obtained from three independent experiments
with at least 10 images taken per treatment. Statistical significance was calculated using
Student’s t-test with the Vassarstats program (http://www.vassarstats.net)
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9. RESULTS
9.1 EHD1 is a regulator of mitochondrial homeostasis
To answer the question whether EHD1 plays a role in mitochondrial fission and
homeostasis, we depleted EHD1 from retinal pigment epithelial (RPE) cells using siRNA
and knocked down approximately 90% of the total EHD1 within the cells (Figure 2.1E).
To compare mitochondrial morphology in mock-treated and EHD1-depleted cells, we
immunostained RPE cells with Tom20, a mitochondrial membrane marker (Figure 2.1AD). Cells lacking EHD1 displayed a highly extended mitochondrial network that had
numerous elongated structures (Figure 2.1B,D) compared to mock-treated cells (Figure
2.1A,C). To quantitatively measure the differences in the mitochondrial networks of
mock-treated and EHD1-depleted cells, we used a plug-in on ImageJ that is specifically
designed to measure the morphology of mitochondria, Mito Morphology Macro
(http://imagejdocu.tudor.lu/doku.php?id=plugin:morphology:mitochondrial_morpholog
y_macro_plug-in:start). Data from multiple cells imaged in three separate experiments
indicated that both the average mitochondrial size (Figure 2.1F) and average
mitochondrial perimeter (Figure 2.1G) are significantly larger in EHD1-depleted cells.
On the other hand, the average circularity is significantly decreased in EHD1-depleted
cells, which indicates that less mitochondrial fission is occurring (Figure 2.1H). In order
to demonstrate that the mitochondrial fragmentation was due to the EHD1-depletion
rather than off-target effects, we performed rescue experiments by knocking down
EHD1 and then reintroducing siRNA-resistant GFP-myc-EHD1 into the knockdown
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Figure 2. 1
EHD1 is required for mitochondrial homeostasis. (A–D) RPE cells were either mock
treated (A,C) or treated with EHD1 siRNA for 72 h (B,D) and immunostained for the
mitochondrial membrane marker Tom20. C and D are images of higher magnitude to
visualize mitochondrial elongation. (E) The efficacy of the EHD1-depletion for A–D is
demonstrated by immunoblotting lysates from mock and EHD1-depleted RPE cells.
(F–H) The Mito Morphology Macro plugin in ImageJ was used to quantify mean±s.d.
for mitochondrial size, perimeter and circularity, in three independent experiments
each using 10 cells per treatment. *P<0.05 (one-tailed Student's t-test). Used with
permission from JCS (Farmer et al., 2017).
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cells (Figure 2.2). As demonstrated (Figure 2.2A-F) and quantified (Figure 2.2G), EHD1depleted cells that were transfected with EHD1 were successfully rescued and displayed
an average mitochondrial size that was significantly shorter than the knockdown cells
and similar to the mock-treated cells. Overall, these data support the notion that EHD1
is needed for mitochondrial homeostasis. Based on the data suggesting an increased
mitochondrial length upon EHD1-depletion, we hypothesized that if EHD1 is a
mediator of mitochondrial dynamics, then the absence of the protein should result in
less dynamic or more static mitochondria compared to mock cells. To test this, we used a
mitochondria-specific dye, Mitotracker Red, to follow mitochondria in living cells. As
shown, in mock-treated cells, the mitochondria are highly dynamic and constantly
undergoing fusion and fission (Figure 2.3A) Images were taken every 15 s for 5 min and
the arrows highlight fission events occurring within the cell. In comparison, the EHD1depleted cells become very static with limited dynamic movement and visible fission
events (Figure 2.3B). These live imaging experiments further support the idea that EHD1
is required for normal mitochondrial fission.
9.2 EHD1 likely functions upstream of Dyn2 and Drp1
To date, Drp1 is considered to be the major protein that regulates mitochondrial
fission (Pitts, Yoon, Krueger, & McNiven, 1999; Santel & Frank, 2008; Taguchi, Ishihara,
Jofuku, Oka, & Mihara, 2007). However, it has recently been determined that the GTPase
Dyn2 is also required to complete the mitochondrial fission (J. E. Lee et al., 2016). Due to
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Figure 2. 2
The elongated mitochondrial phenotype is rescued when EHD1 is reintroduced
into EHD1 knock-down cells. (A-F) RPE cells were Mock-treated (A, C, E) or treated
with EHD1-siRNA (B, D, F) for 72 h. Some of the cover-slips containing Mock or
EHD1 knock-down cells were further transfected with a siRNA-resistant GFP-MycEHD1 cDNA (si-GFP-myc-EHD1) for the last 24 h (C-F). All cells were fixed and
immunostained with antibodies against Tom20 (A-F). GFP-Myc-EHD1 transfected
cells are seen in green, Bar, 10 µm. (G) At least 7 cells from each treatment (in 3
independent experiments) in A-F were analyzed by Mito Morphology Macro plugin
in ImageJ and the mean+/-s.d. for size of their mitochondria was plotted. * denotes p
values of less than 0.05, and n.s. denotes differences that are not statistically
significant (p>0.05). Used with permission from JCS (Farmer et al., 2017).
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Figure 2. 3
Mitochondrial dynamics are impaired upon EHD1 depletion. Live imaging was
performed on RPE cells incubated with Mitotracker Red and either mock treated (A)
or treated with EHD1 siRNA for 72 h (B). 4-slice z-section images were taken every 15
s for 5 min for each treatment, and compiled to a maximal projection image. The
arrows depict examples of fission events in mock-treated cells. Used with permission
from JCS (Farmer et al., 2017).
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the significant homology between EHD1 and dynamin (Daumke et al., 2007), and the
fact that EHD1 is an ATPase involved in endosomal fission (Cai et al., 2013; Cai et al.,
2014; Deo et al., 2018; Jakobsson et al., 2011), we hypothesized that EHD1 directly
mediates fission at the mitochondrial membrane. To answer this hypothesis, we used a
STS assay to induce mitochondria fragmentation in either mock-treated or EHD1depleted cells. STS is a global kinase inhibitor that induces mitochondrial fission and
fragmentation through the activation of Drp1 and Dyn2. If Drp1 or Dyn2 are absent
from the cells, fragmentation does not occur when induced by STS (J. E. Lee et al., 2016).
We therefore rationalized that if EHD1 plays a similar role to Drp1 and Dyn2 in
mitochondrial fission, the absence of EHD1 would protect the cells from STS-induced
mitochondrial fragmentation as well. Accordingly, mock-treated and EHD1-depleted
cells were either treated with or without STS for 1 h. The cells were then immunostained
with antibodies for Tom20 to visualize the mitochondria morphology. EHD1-depleted
cells displayed a network of elongated mitochondria compared to mock-treated cells
(compare Figure 2.4B to 2.4A). The mitochondria in the EHD1-depleted cells displayed a
greater average size (Figure 2.4E) and perimeter (Figure 2.4F) but significantly decreased
circularity (Figure 2.4G), consistent with Figure 1 data. As anticipated, mock-treated
cells that were subject to STS treatment resulted in mitochondria that underwent fission
and fragmentation (compare Figure 2.4B with 2.4A), and the STS-induced cells had
significantly decreased average size (Figure 2.4E) and perimeter (Figure 2.4F), but
significantly increased circularity (Figure 2.4G). As demonstrated, EHD1-depleted cells
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Figure 2. 4
EHD1 plays a regulatory role in mitochondrial fission. (A–D) RPE cells were either
mock treated (A,B) or treated with EHD1 siRNA for 72 h (C,D), followed by
incubation with STS for the last 1 h of treatment (B,D) or without the drug (A,C). (E–
G) The Mito Morphology Macro plugin in ImageJ was used for quantifying
mean±s.d. for mitochondrial size, perimeter and circularity in three independent
experiments each using 10 cells per treatment. *P<0.05; n.s., not statistically
significant (one-tailed Student's t-test). Used with permission from JCS (Farmer et al.,
2017).
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subject to STS treatment clearly resulted in fission and fragmentation of the
mitochondria (Figure 2.4D), and the mitochondria size, perimeter, and circularity were
not significantly different than the mock-treated cells subject to STS treatment (Figure
2.4E-G). While we cannot completely rule out the possibility that EHD1 plays a direct
role in mitochondrial fission, these data support the idea that EHD1 most likely acts
upstream of Drp1 and Dyn2 in the process of mitochondrial fission.
9.3 EHD1 and Rabankyrin-5 regulate the retromer control of mitochondrial
homeostasis
Previous studies have identified VPS35, a component of the retromer cargo
selection complex, as a key regulator of mitochondria homeostasis and PD (Kumar et al.,
2012; Struhal et al., 2014; W. Wang et al., 2017; W. Wang et al., 2016; Zimprich et al.,
2011). One recent model suggests that VPS35 is responsible for the transport of the
ubiquitin ligase Mul1 to the mitochondrial membrane where Mul1 ubiquitinates the
mitochondrial fusion protein, Mfn2, resulting in proteasomal degradation (Tang et al.,
2015) (see model, Figure 2.5A). Since our lab has previously described an interaction
between EHD1, Rabankyrin-5, and the retromer complex, we hypothesized that EHD1
depletion might interfere with Mul1 trafficking to the mitochondrial membrane. In this
scenario, increased levels of Mfn2 on the mitochondrial membrane might skew the
fusion-to- fission ratio, resulting in an elongated mitochondria phenotype. To test this
hypothesis, we first tested whether or not EHD1 interacted with Mul1. As a positive
control, we confirmed that GST-EHD1 and the EH domain of EHD1 (EH1) pulled down
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Figure 2. 5
EHD1 interacts with Mul1. (A) Model for the potential role of EHD1 in regulating
mitochondrial dynamics via Mul1. Under normal conditions, the ubiquitin ligase
Mul1 is released from an interaction with VPS35 and the retromer components
(including EHD1), and relocates to the mitochondrial membrane, where it
ubiquitinates Mfn2, inducing its proteasomal degradation and promoting normal
mitochondrial fission. Upon EHD1 depletion, Mul1 would be retained in association
with VPS35 and the retromer, preventing Mfn2 degradation and thus enhancing
mitochondrial membrane fusion. (B) GST pulldown from bovine brain cytosol was
performed with GST only, a GST-tagged EH domain of EHD1 (GST–EH1) and GST–
EHD1. Eluates were immunoblotted with antibodies against MICAL-L1 (top panel),
as a positive interactor with EHD1, and Mul1 (middle panel). GST fusion protein
samples were immunoblotted with anti-GST (bottom panel). (C) Coimmunoprecipitation (IP) of proteins from a HeLa cell lysate using anti-Mul1
(αMul1), and immunoblotted with anti-Vps26 and anti-rabankyrin-5 antibodies. 25
kDa immunoglobulin light chains detected by the secondary anti-light chain
antibody are indicated in the bottom panel. Used with permission from JCS (Farmer
et al., 2017).
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the known EHD1 interaction partner MICAL-L1 from bovine brain cytosol (Figure 2.5B,
top panel), consistent with our previous results (Sharma, Giridharan, et al., 2009).
Additionally, the purified GST-EHD1 pulled down Mul1 from the bovine brain cytosol,
whereas the GST and GST-EH1 were unable to (Figure 2.5B, middle panel). To further
elucidate the relationship between EHD1, Rabankyrin-5, the retromer, and Mul1, we
performed co-immunoprecipitation experiments with endogenous levels of proteins
(Figure 2.5C). In these biochemical assays, we were able to show that an antibody
against Mul1 pulled down a component of the retromer complex, VPS26, as anticipated.
However, in the same experiment, we also showed that Mul1 pulled down Rabankyrin5 (Figure 2.5C), and low levels of EHD1 (data not shown). These experiments suggest
that EHD1 and Rabankyrin-5 interact with Mul1 to mediate its transport to
mitochondria, where it regulates Mfn2 degradation.
We rationalized that if Rabankyrin-5 and EHD1 are cooperating together with
the retromer to transport Mul1 to the mitochondrial membrane, then depletion of
Rabankyrin-5 should result in a phenotype similar to EHD1-depletion. To test this, RPE
cells were depleted of Rabankyrin-5 and immunostained with Tom20 to analyze the
mitochondrial-morphology compared to mock-treated cells. As demonstrated,
Rabankyrin-5-depleted cells displayed an elongated network of mitochondria compared
to mock-treated cells (compare Figure 2.6B to 2.6A). Quantification of three independent
experiments showed that the average size and perimeter of Rabankyrin-5-depleted cells
were greater than mock-treated cells, whereas the mitochondrial circularity was
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Figure 2. 6
Rabankyrin-5 mediates the interaction between EHD1 and Mul1, and its depletion
induces an elongated mitochondrial network similar to that observed upon EHD1
depletion. (A,B) RPE cells were either mock treated (A) or treated with rabankyrin-5
siRNA for 72 h (B) and immunostained for the mitochondrial membrane marker
Tom20. (C) The Mito Morphology Macro plugin in ImageJ was used for quantifying
mean±s.d. for mitochondrial size, perimeter and circularity in three independent
experiments each using 10 cells per treatment. *P<0.05 (one-tailed Student's t-test).
(D) HeLa cells were either mock treated or treated with Rabankyrin-5 siRNA, lysed,
and subjected to a GST–EHD1 pulldown, and immunoblotted with Mul1 (upper
panel). The efficacy of the Rabankyrin-5-depletion is demonstrated by
immunoblotting lysates from mock-treated and Rabankyrin-5-depleted cells (bottom
two panels). Used with permission from JCS (Farmer et al., 2017).
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significantly decreased in Rabankyrin-5-depleted cells (Figure 2.6C).
Since the EHD1 and Mul1 interaction appeared less robust than that of
Rabankyrin-5 and Mul1, and because EHD1 is a direct interaction of Rabankyrin-5
(Zhang, Reiling, et al., 2012), we postulated that Rabankyrin-5 might potentially mediate
the interaction between EHD1 and Mul1. To test this idea, we used lysates from mocktreated or Rabankyrin-5-depleted cells in pulldowns using GST-EHD1 as bait.
Incubation of mock-treated lysate with GST-EHD1 resulted in significant Mul1 being
pulled down, whereas the GST alone did not (Figure 2.6D, top panel). However,
efficiently depleting Rabankyrin-5 from lysates (Figure 2.6D, middle panel) and
incubating it with GST-EHD1 resulted in very little Mul1 being pulled down (Figure
2.6D, top panel), suggesting that Rabankyrin-5 mediates the interaction between EHD1
and Mul1.
If the mitochondrial elongation phenotype observed upon EHD1- or Rabankyrin5-depletion is due to the stabilization of Mfn2 on the mitochondrial membrane, one
would predict that the levels of Mfn2 would increase under these conditions compared
to mock-treated cells. To test this idea, we depleted EHD1, Rabankyrin-5, or VPS35 and
compared the protein expression of Mfn2, Drp1, and actin (loading control) to mocktreated cells. siRNA treatment of HeLa cells resulted in efficient depletion of all three
proteins (Figure 2.7A, top panels, and quantified in Figure 2.7B-G), whereas actin levels
remain relatively unchanged in the mock- and siRNA-treated cells (Figure 2.7A, bottom

81

82
Figure 2. 7
Depletion of EHD1, Rabankyrin-5 or VPS35 does not induce Mfn2
accumulation. HeLa cells were either mock treated, or treated with EHD1,
Rabankyrin-5 or Vps35 siRNA for 72 h. Depletion efficacy was validated by
immunoblotting with antibodies against EHD1, Rabankyrin-5 and VPS35 (A; top
three panels), and the effect of the siRNA was assessed with antibodies against Mfn2
(A; second panel from the top), Drp1 (A; third panel from the top) and actin (A;
bottom panel). (B–G) Densitometric quantification from three separate experiments.
*P<0.05 (one-tailed Student's t-test). Used with permission from JCS (Farmer et al.,
2017).
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panels). However, no difference was observed in the protein expression level of Mfn2 or
Drp1 (Figure 2.7A, middle two panels), and no major changes in the Drp1 association
and/or distribution along mitochondria was noted (data not shown). Data from these
experiments suggest that despite the ability of EHD1 and Rabankyrin-5 to interact with
Mul1, accumulation of Mfn2 and/or Drp1 on the mitochondrial membrane was likely
not the mechanism by which EHD1 and Rabankyrin-5-depletion induce elongated
mitochondria.
9.4 EHD1 and Rabankyrin-5 differentially regulate VPS35 to control mitochondrial
fission
Our previous results were unable to validate the notion that VPS35 is responsible
for regulating Mfn2 levels through Mul1. However, a recent study presents an
alternative model by which VPS35 and the retromer affect mitochondrial homeostasis by
interacting with Drp1. The model suggests that retromer-containing vesicles remove
inactive Drp1 from the mitochondrial membrane, enabling active Drp1 to occupy the
receptors on the mitochondria to mediate fission (W. Wang et al., 2017) (see model in
Figure 2.8L). In this model, depletion or sequestration of VPS35 would impair fission
and induce formation of elongated mitochondria. We therefore hypothesized that EHD1
regulates VPS35 expression or localization. To test this, we immunoblotted lysates that
were either mock-treated or EHD1-depleted (Figure 2.8A). Upon efficient EHD1depletion (Figure 2.8A), there was a consistent reduction in VPS35 to approximately 50%
of the levels detected in mock-treated cells, suggesting that EHD1’s presence stabilizes
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Figure 2. 8
Depletion of EHD1 and Rabankyrin-5 results in reduced and sequestered VPS35,
respectively. (A–D) HeLa cells were either mock treated, treated with EHD1 siRNA
(A) or treated with rabankyrin-5 (Rank-5) siRNA (C) for 72 h and immunoblotted for
VPS35, EHD1, Rabankyrin-5 and actin. The asterisk (in A) indicates reduced VPS35
protein levels. (B,D) Quantification of protein levels from three independent
experiments. *P<0.05 (one-tailed Student's t-test). (E–J) RPE cells were either mock
treated (E,G,I) or treated with rabankyrin-5 siRNA for 72 h (F,H,J), and
immunostained for VPS35 and the Golgi membrane marker GM130. Regions of
interest were drawn with a dashed line around the GM130 Golgi stain (I,J) and
superimposed in the merged images (E,F) and in the VPS35-stained images (G,H;
note, the region of interest is not shown in G and H so the VPS35 distribution pattern
can be observed more clearly). Scale bar: 10 μm. (K) ImageJ was used to quantify the
mean±s.d. for fluorescence of VPS35 localized to the central Golgi region marked by
the regions of interest in three independent experiments each using 10 cells per
treatment. *P<0.05 (one-tailed Student's t-test). (L) Current working model showing
the proposed mechanism for EHD1 regulation of mitochondrial dynamics. In this
scenario, EHD1 might act in facilitating fission of vesicles that transport VPS35 from
endosomes to the mitochondrial membrane. VPS35 might then interact with inactive
Drp1, removing it from the mitochondrial membrane and facilitating the function of
active Drp1 leading to mitochondrial fission. Thus, the absence of EHD1 might
prevent this transport step and lead to elongated mitochondria. Used with
permission from JCS (Farmer et al., 2017).
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VPS35 (Figure 2.8A, asterisk, and quantified in 2.8B). Additionally, the levels of VPS26
were tested and were similarly decreased when EHD1 was depleted. Moreover, these
experiments support the idea that VPS35 and the retromer control mitochondrial fission
by removing inactive Drp1, thus allowing fission by active Drp1 (Figure 2.8L).
We went on to test whether Rabankyrin-5 similarly affects VPS35 protein levels.
To our surprise, Rabankyrin-5-depleted cells had no impact on VPS35 expression levels
(Figure 2.8C, quantified in 2.8D), leading us to hypothesize that Rabankyrin-5 regulates
VPS35 in a manner that is distinct from that of EHD1. One potential mechanism is that
Rabankyrin-5 is needed for the trafficking of VPS35-positive endosomes to the inactive
Drp1 on the mitochondrial membrane. We therefore argued that if Rabankyrin-5 does
regulate the trafficking of VPS35, then depletion of Rabankyrin-5 should result in an
altered VPS35 localization pattern. To test this, we depleted Rabankyrin-5 and compared
the subcellular distribution of VPS35 to mock-treated cells using GM130 to mark the
Golgi region as a reference point within the cell (Figure 2.8E-J). As demonstrated,
Rabankyrin-5-depleted cells had a significant degree of sequestration of VPS35 in the
Golgi region as compared to mock-treated cells (Figure 2.8, compare F and H to E and G;
dashed region of interest are the Golgi, as marked by GM130 in I and J). To quantify this,
we measured the VPS35 fluorescence localized to the Golgi region and found that it was
significantly higher in the Rabankyrin-5-depleted cells compared to mock-treated cells
(Figure 2.8K). Overall, these experiments support a model by which depletion of EHD1
and Rabankyrin-5 lead to a reduced level of VPS35 or an altered VPS35 subcellular
distribution, respectively. This in turn prevents VPS35 from being able to traffic to the
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mitochondrial membrane to remove inactive Drp1, culminating in impaired fission, thus
leading to the elongated network of mitochondria observed in these cells.
10. SUMMARY AND CONCLUSIONS
Mitochondrial dynamics have long been correlated with their cellular functions
and mitochondrial morphology appears along a continuum from a network of tubular
structures to smaller fragmented membranes (Benard et al., 2006). Indeed, early
observations of mitochondria found that upon activation of ATP synthesis,
mitochondria displayed a smaller and more condensed phenotype (Hackenbrock, 1966).
Additionally, mitochondrial fragmentation has been observed in patient fibroblasts that
have altered energy production due to defects in respiratory chain subunits (Capaldi,
Murray, Byrne, Janes, & Marusich, 2004; Koopman et al., 2005). Since mitochondrial
dynamics are highly regulated, researchers have extensively studied mitochondrial
fusion and fission and the proteins that regulate these processes. In particular, the role of
fission was thought to be controlled by one GTPase, Drp1 (Bleazard et al., 1999;
Labrousse et al., 1999). However, a recent study has shed new light on the mechanism of
mitochondrial fission and has identified the GTPase Dyn2 in playing a sequential role to
Drp1 to mediate cleavage of mitochondrial membranes (J. E. Lee et al., 2016).
In addition to the focus on the proteins carrying out the process of fission and the
recent mechanism by which Drp1 and Dyn2 facilitate fission, exciting new studies have
implicated a role for VPS35 and the retromer in PD and mitochondrial dynamics,
forging a novel connection between endocytic regulatory complex and a non-endocytic
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organelle (Follett, Bugarcic, Collins, & Teasdale, 2017; Follett et al., 2014; Kumar et al.,
2012; Sharma et al., 2012; Struhal et al., 2014; Tang et al., 2015; Vilarino-Guell et al., 2011;
Zimprich et al., 2011). However, while the relationship between VPS35, mitochondrial
dynamics, and PD is now irrefutable, the precise mechanism(s) by which VPS35 controls
fusion or fission remains somewhat controversial.
In Chapter II, we identify a novel regulatory role for EHD1 as an effector of
mitochondrial fission. We demonstrated that upon EHD1-depletion, the mitochondria
become more elongated and static, similar to the phenotype upon Drp1-depletion or
mutation (Benard et al., 2007). Since EHD1 is an ATPase with homology to the dynamin
family of GTPases (Daumke et al., 2007; Melo et al., 2017), it raised the question as to
whether EHD1 plays a role in mitochondria fission in a similar manner to Drp1 and
Dyn2. However, no significant localization of EHD1 was observed with the
mitochondrial membrane, reducing the likelihood that EHD1 plays a direct role in
mitochondrial fission. In addition, upon STS treatment of EHD1-depleted cells, the
mitochondria nonetheless underwent fragmentation, as opposed to what occurs upon
Drp1 or Dyn2 depletion (J. E. Lee et al., 2016). This suggests that the kinase inhibitor
likely activates Drp1 and/or Dyn2 directly, bypassing the potential regulatory role
carried out by EHD1.
Since it is unlikely that EHD1 directly regulates mitochondrial fission, we asked
what could be the potential role of EHD1 upstream of Drp1 and Dyn2. Previous studies
in our lab and others have linked EHD1 to the retromer complex (Gokool et al., 2007;
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Zhang, Reiling, et al., 2012), suggesting the possibility that EHD1 somehow functions
upstream of the mitochondrial fission proteins. One potential model suggests that
VPS35 and the retromer regulate the transport of the ubiquitin ligase Mul1 to the
mitochondria (Tang et al., 2015; Yun et al., 2014). In this model, if Mul1 and VPS35 lose
their interaction, Mul1 traffics to the mitochondria, where it ubiquitinates the fusionpromoting protein Mfn2. Ubiquitination of Mfn2 targets it for proteasomal degradation
thus reducing the amount of fusion and leading to a more fragmented phenotype (Tang
et al., 2015). While we did demonstrate that Mul1 interacts with EHD1, through the
EHD1 interaction partner Rabankyrin-5, which also interacts with the retromer (Zhang,
Reiling, et al., 2012), we did not find increased levels of Mfn2 upon depletion of EHD1,
Rabankyrin-5, or VPS35 as would be anticipated if less proteasomal degradation occurs.
This suggests that the interactions between EHD1, Rabankyrin-5, VPS35, and Mul1 are
not the primary mechanism for the control of mitochondrial dynamics.
Another model has been proposed that VPS35 regulates mitochondrial
dynamics by a different mechanism where VPS35-containing vesicles interact with
inactive Drp1 on the mitochondrial membrane and remove the inactive Drp1. As a
result, Drp1 receptors are freed up to bind to active Drp1 and promote fission of the
mitochondria (W. Wang et al., 2017). In this model, loss or altered regulation of VPS35 in
the absence of EHD1 could lead to impaired fission resulting in an elongated and static
mitochondrial network. Indeed, we demonstrated that depleting EHD1 from cells
resulted in a decrease in VPS35 protein levels. Surprisingly, Rabankyrin-5-depletion did
not result in a decrease in VPS35 proteins levels similar to EHD1. However, when
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Rabankyrin-5 was depleted, the subcellular localization of VPS35 was altered, providing
a mechanism for the formation of elongated mitochondria that is different from EHD1.
While our data suggest that EHD1 and Rabankyrin-5 play a regulatory function
upstream of mitochondrial fission through VPS35, we cannot rule out other potential
roles that EHD1 and Rabankyrin-5 may play in fission or fusion of mitochondria,
including the possibility that EHD1 might serve (at least in part) as a direct
mitochondrial membrane fission protein.
In summary, Chapter II highlights a new mechanism of regulation of
mitochondrial dynamics and further strengthens the growing crosstalk between
endocytic regulatory proteins and non-endocytic organelles. While no mutations or
impaired expression of EHD1 or Rabankyrin-5 has been documented thus far in PD,
expanding the knowledge of key regulators of mitochondrial dynamics is likely to shed
new light on mechanisms that lead or contribute to PD.
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Chapter III

The Retromer facilitates the localization of Bcl-xL to the outer mitochondrial
membrane

With permission from Molecular Biology of the Cell, parts of this chapter were derived
from: (Farmer et al., 2019)

Farmer, T., K.L. O'Neill, N. Naslavsky, X. Luo, and S. Caplan. 2019. Retromer facilitates
the localization of Bcl-xL to the mitochondrial outer membrane. Mol Biol Cell. 30:11381146
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11. ABSTRACT
The Bcl-2 family member Bcl-xL is an anti-apoptotic protein that plays a critical
role in whether a cell lives or dies by protecting the integrity of the mitochondrial outer
membrane (MOM). Bcl-xL works through a mechanism in which it prevents pore
formation at the MOM but how Bcl-xL is recruited to the MOM is not fully understood.
The retromer is a conserved endosomal scaffold complex involved in membrane
trafficking. In Chapter III, we identify two core components of the retromer, VPS35 and
VPS26, as novel regulators of the recruitment of Bcl-xL to the MOM. We observed
interactions and colocalization between Bcl-xL, VPS35, VPS26, and MICAL-L1, the latter
a protein that regulates tubular recycling endosomes and also interacts with the
retromer. We also discovered that if VPS35 is depleted from cells, the levels of Bcl-xL
that remain unassociated with MOM were significantly increased. Our results from this
study suggest that the retromer regulates apoptosis by facilitating Bcl-xL’s transport to
the MOM. Importantly, this chapter suggests a novel, previously uncharacterized
relationship between machinery controlling apoptosis and endosomal trafficking.
12. INTRODUCTION
Apoptosis is an essential cellular event that is required for normal development
and the maintenance of tissue homeostasis, protection from genomic instability and
mutation, and the control of humoral immune responses (Slomp & Peperzak, 2018). The
Bcl-2 family of proteins consists of apoptosis regulators that are either pro-apoptotic
(Bax, Bak, Bad, etc.) or anti-apoptotic (Bcl-2, Bcl-xL, Mcl-1, etc.) proteins (Adams & Cory,
1998; Farrow & Brown, 1996; Fuchs & Steller, 2015). On one hand, interference with the
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key regulators of apoptosis may lead to uncontrolled cell growth and pathologies that
include breast (Placzek et al., 2010; Tawfik, Kimler, Davis, Fan, & Tawfik, 2012) and lung
(Han et al., 2002; Viard-Leveugle, Veyrenc, French, Brambilla, & Brambilla, 2003) cancer,
as a result of decreased cell death. On the other hand, increased cell death can lead to
neurodegenerative disorders such as Alzheimer’s (Crews, Patrick, Adame, Rockenstein,
& Masliah, 2011; M. H. Lee et al., 2010) and PD (Barcia et al., 2011; Berry, La Vecchia, &
Nicotera, 2010). Bcl-xL is a vital anti-apoptotic protein that is up-regulated in a variety of
cancers and increases the cell’s resistance to undergo apoptosis (Choi et al., 2016; Scherr
et al., 2016). While Bcl-xL can function through a number of mechanisms, the main mode
of action is sequestering the pro-apoptotic proteins Bax and Bak, thus preventing the
formation of pores in the MOM and subsequent release of cytochrome c that activates
caspases and downstream death signals (Oltvai, Milliman, & Korsmeyer, 1993; Shimizu
et al., 1995; Yang et al., 1995). Bcl-xL mainly localizes to the MOM but also is partially
localized to the cytoplasm before reaching the MOM (Hausmann et al., 2000; Y. T. Hsu,
Wolter, & Youle, 1997; Nijhawan et al., 2003). While the signals that recruit Bcl-xL are
unclear, some cellular signals result in the recruitment of Bcl-xL to the mitochondria (Y.
T. Hsu et al., 1997), suggesting that Bcl-xL translocation from the cytosol to the
mitochondria might be an important regulatory step in the apoptotic cascade. Clues to
how Bcl-xL might be translocated to the mitochondria can be found in previous studies
that have addressed other Bcl-2 family members. For example, Bax undergoes simple
diffusion from the cytoplasm to the mitochondria (Wolter et al., 1997) and given the
homology between Bcl-xL and Bax, one possibility is that Bcl-xL also undergoes simple
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diffusion to the MOM. However, few studies have addressed the mechanism by which
Bcl-xL is translocated and targeted to the mitochondrial membrane to prevent Bax and
Bak pore formation.
In addition to diffusion as a potential mechanism for Bcl-2 family member
translocation from the cytosol to MOM, other mechanisms of transport might also
contribute. One possibility is that endocytic membrane trafficking might account for
some of the Bcl-xL translocation to the MOM. While endocytic regulatory proteins are
primarily responsible for regulating the internalization, sorting, and recycling of
proteins and lipids from the PM (Naslavsky & Caplan, 2018), recent studies suggest that
endocytic membrane trafficking proteins are responsible for a variety of non-endocytic
cellular events, such as mitochondrial fission (Farmer et al., 2017; J. E. Lee et al., 2016)
and centriole disengagement/duplication (Xie et al., 2018). For example, EHD1 is a key
regulator of receptor recycling to the plasma membrane (Caplan et al., 2002; Guilherme
et al., 2004) and also regulates both mitochondrial fission (Farmer et al., 2017) and
centriole disengagement (Xie et al., 2018). Furthermore, the endocytic scaffolding
complex known as the retromer, consisting of VPS26, VPS29, and VPS35, and two
sorting nexin proteins, has also been implicated in mitochondrial fission (Farmer et al.,
2017; Naslavsky & Caplan, 2018; Tang et al., 2015; W. Wang et al., 2017) and centriole
disengagement (Xie et al., 2018). The retromer subunit, VPS35, also directly interacts
with and regulates multiple mitochondrial fission and fusion factors including the E3
ligase Mul1 (Braschi et al., 2010; Tang et al., 2015) and the fission factor, Drp1 (Farmer et
al., 2017; Tang et al., 2015; W. Wang et al., 2017). Interestingly, Bcl-xL and Drp1 interact
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and colocalize on clathrin-associated vesicles (Li et al., 2013), suggesting a potential
control mechanism for Bcl-xL by endocytic regulatory proteins. Accordingly, we
hypothesized that VPS35 and the retromer interact with Bcl-xL and control the
translocation of Bcl-xL from the cytosol to the MOM, thus influencing apoptosis.
In Chapter III, we address whether the retromer and endocytic trafficking directs Bcl-xL
translocation from the cytoplasm to the MOM. We demonstrate for the first time that
Bcl-xL physically interacts with the retromer components VPS35 and VPS26 in a Drp1independent manner. Furthermore, the retromer and Bcl-xL colocalize on vesicles that
are distinct from mitochondria. Significantly, the depletion of VPS35, which disrupts
retromer function, results in reduced Bcl-xL on mitochondria and increases the rate of
STS-induced apoptosis. While only a portion of the Bcl-xL seems to rely on the retromer
to translocate to the MOM, our studies suggest a previously uncharacterized pathway
for delivering Bcl-xL to the MOM that potentially has a significant consequence if
disrupted.
13. MATERIALS AND METHODS
13.1 Reagents and antibodies
Staurosporine was purchased from Sigma Aldrich (S5921). Z-valine-alanineaspartic acid-(OMe)-fluromethylketone (Z-VAD) was purchased from Fisher Scientific
(MP Biomedical; MP3FK00901). Commercial antibodies with their specific use (IB,
immunoblotting; IF, immunofluorescence; and IP, immunoprecipitation) and catalogue
numbers are indicated. Anti-VPS26 (IB, IF, IP, ab23892), anti-VPS35 (IB, ab157220), anti-
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Bcl-xL (IB, IP, ab32370), anti-Bcl-xL (IF, ab26035), anti-Parp1 (IB, ab137653), and antiRab5 (IF, ab18211) were from Abcam; anti-DRP1 (IB, 611112) was from BD Cell Analysis;
anti- MICAL-L1 (IB, IF, MBS9215151) was from MyBioSource; anti-Tom20 (IF, sc-11415)
was from Santa Cruz Biotechnology; anti-EEA1 (IF, #3288) was from Cell Signaling; and
anti-GAPDH-HRP (IB, HRP-60004) was from Protein Tech; donkey anti-mouse
immunoglobulin (IgG) light chain–HRP (IB, 715-035-151) and mouse anti-rabbit IgG
light chain–HRP (IB, 211-032-171) were from Jackson; mouse anti-rabbit IgG heavy
chain–HRP (IB, ab99702) was from Abcam; donkey anti-mouse 488 (IF,A21202), donkey
anti-mouse 568 (IF, 21043), goat anti-rabbit 488 (IF, A11034), goat anti-rabbit 568 (IF,
A11036), and goat anti-rabbit 633 (IF, A21070) were from Molecular Probes.
13.2 Cell Culture
The HeLa cervical cancer cell line was obtained from ATCC and grown in high
glucose DMEM containing 10% FBS, 1x penicillin-streptomycin (Invitrogen), and 2 mM
glutamine. The immortalized retinal pigment epithelium (RPE) cell line from ATCC was
gown in high glucose DMEM containing 10% FBS, 1x penicillin-streptomycin
(Invitrogen), 2 mM glutamine, and 2 mM non-essential amino acids. The CRISPR/Cas9
HCT 116 cells lacking endogenous Bak and Bax, with GFP-tagged Bax knocked in (GFPBax HCT 116) have been previously described (K. L. O'Neill, Huang, Zhang, Chen, &
Luo, 2016)) and were grown in McCoy’s medium containing 10% FBS, 1× penicillinstreptomycin (Invitrogen), and 2 mM glutamine.
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13.3 Transfection and siRNA treatment
Transfection of RPE cells for 24 h at 37°C was performed using Fugene6
(Promega) according to the manufacturer’s protocol. Smart-pool ON-Target Drp1,
VPS35, and MICAL-L1 oligonucleotides were obtained from Dharmacon. RPE, HeLa, or
GFP-Bax HCT 116 cells were transfected using Dharmafect 1 transfection reagent
(Dharmacon) with 40 nM oligonucleotide. The knockdown efficiency of the protein was
measured at 72 h post-transfection by immunoblotting for each experiment.
13.4 Plasmids
mCherry-TOMM20 was a gift from Michael Davidson (Addgene; plasmid
#55146).
13.4 Co-immunoprecipitation
HeLa cells were grown in 100-mm dishes until confluent. Cells were lysed with
lysis buffer containing 50 mM Tris, pH 7.4, 100 mM NaCl, 0.5% Triton X-100, and 1×
protease cocktail inhibitor (Millipore) on ice for 30 min. Lysates were incubated with
anti–Bcl-xL, anti-VPS26, or anti–MICAL-L1 antibody at 4°C overnight. Protein G beads
(GE Healthcare) were added to the lysate-antibody mix at 4°C for 4 h. Samples were
then washed three times with the same lysis buffer. Proteins were eluted from the
protein G beads by boiling in the presence of 4× loading buffer (250 mM Tris, pH 6.8, 8%
SDS, 40% glycerol, 5% β-mercaptoethanol, 0.2% bromophenol blue) for 10 min. Eluted
proteins were then identified by immunoblotting.
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13.5 Immunoblotting
Cells were washed twice in ice-cold 1x PBS and then scraped off plates with a
rubber policeman into ice-cold lysis buffer (50 mM Tris, pH 7.4, 100 mM NaCl, 0.5% TX100, 1× protease cocktail inhibitor [Millipore]). Protein levels of post-nuclear lysates were
quantified using the Bradford assay (BioRad) for equal protein level loading. For
immunoblotting, 20–30 μg of protein per lysate (from either HeLa, RPE1, or GFP-Bax
HCT 116 cells) was separated by SDS–PAGE. Proteins were transferred onto
nitrocellulose membranes, and blocked for 30 min at room temperature in 1x PBST plus
5% nonfat dry milk. The membranes were then incubated overnight at 4°C or for 1 h at
room temperature with primary antibodies diluted in 1x PBST. Membranes were then
washed three times with 1x PBST and incubated at room temperature with appropriate
secondary antibodies diluted in 1x PBST for 30 min. The membranes were then washed
again three times with 1x PBST, before enhanced chemiluminescence was used to detect
the proteins.
13.6 Mitochondrial enrichment
HeLa cells were grown in 100-mm dishes and subject to either Mock- or VPS35siRNA treatment for 72 h. Cells were homogenized in buffer containing 150 mM NaCl,
10 mM Tris, pH 6.8, 10 mM KCl, and 1 M sucrose. Homogenates were incubated with
anti-Tom20 and rotated at room temperature for 10 min. Homogenates plus anti-Tom20
were added to Dynabeads Protein G (Invitrogen) and rotated for 10 min at room
temperature. The samples were placed on the magnet and the supernatant was collected
for the non-mitochondrial fraction. The Dynabeads or mitochondrial fraction was
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washed three times with the cell homogenization buffer. The beads and supernatant
were subject to lysis in equal volumes with lysis buffer containing 50 mM Tris, pH 7.4,
100 mM NaCl, 0.5% Triton X-100, and 1× protease cocktail inhibitor (Millipore) on ice for
30 min. Loading buffer (4×) was added to each fraction and boiled for 10 min. Equal
volumes were separated by SDS–PAGE and proteins were detected by immunoblotting
with anti–Bcl-xL and anti-Tom20 antibodies.
13.7 Quantification of immunoblots
The adjusted relative density of the immunoblots was measured in Fiji ImageJ
according to the following protocol:
www1.med.umn.edu/starrlab_deleteme/prod/groups/med/@pub/@med/@starrlab/docu
ments/content/med_content_370494.html.
13.8 Immunofluorescence.
RPE or GFP-Bax HCT 116 cells were treated as indicated in the text and then
fixed in 4% paraformaldehyde in 1x PBS for 10 min at room temperature. Cells were
then washed three times in 1x PBS. The cells were then incubated with primary antibody
in staining buffer (1x PBS containing 0.5% bovine serum albumin (BSA) and 0.2%
saponin) for 1 h at room temperature, washed three times in 1x PBS and then incubated
with the appropriate fluorochrome-conjugated secondary antibodies diluted in staining
buffer for 30 min. Cells were washed three times in 1x PBS and mounted on microscope
slides with Fluoromount.
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Using a Zeiss LSM800 confocal microscope with a 63×/1.4 NA oil objective, zstack confocal images were collected. The series of images from a z-stack was then
processed into a 3D projection, and a 3D snapshot was obtained using the Zeiss Zen
Software. Similarly, 3D rotational videos were generated from the same 3D projections
using the Zeiss Zen Software. For quantification, collected 3D snapshots were imported
into Fiji ImageJ as described below.
13.9 Colocalization quantification
Colocalization between mCh-TOMM20 and Bcl-xL, VPS26 and Bcl-xL, VPS26
and mCh-TOMM20, Bcl-xL and Rab5, or Bcl-xL and EEA1 were assessed in Fiji ImageJ.
Multichannel 3D snapshots were split into separate channels. A region of interest was
drawn around individual cells in one of the two channels, using the “freehand” tool.
This region was then subject to the colocalization threshold plugin, and colocalization
was measured and calculated.
13.10 Bax activation assay
GFP-Bax HCT 116 cells were subject to either Mock- or VPS35-siRNA treatment.
In the last 60 min of the siRNA treatment, the cells were treated with 1 μM staurosporine
(Sigma Aldrich). Cells were immunostained with anti-Tom20 as previously described.
250 cells per treatment were designated as either having inactive (cytoplasmic) Bax or
active (punctate) Bax.
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13.11 Parp1 cleavage assay
GFP-Bax HCT 116 cells were subject to Mock- or VPS35-siRNA treatment. The
cells were detached using trypsin and treated with 1 μM staurosporine for 0, 30, or 60
min while continuously being rotated at 37°C. Immunoblotting was performed on the
samples with anti-Parp1. The amount of full-length Parp1 was quantified by the method
described above.
13.12 Statistics
Data from Fiji ImageJ were imported into Microsoft Excel. The mean and the
standard deviation of the mean were calculated from data obtained from three
independent experiments with at least 10 images taken per treatment. Statistical
significance was calculated using a Student’s t test with the Vassarstats program
(http://www.vassarstats.net).
14. RESULTS
14.1 Bcl-xL resides in a protein complex with endocytic proteins and DRP1
Bcl-xL localizes to the MOM where it regulates apoptosis, but a pool of the
protein can been observed in the cytoplasm (Hausmann et al., 2000; Y. T. Hsu et al.,
1997; Nijhawan et al., 2003). Previous studies suggest a diffusion mechanism for some
Bcl-2 family members from the cytosol to the MOM, where the proteins become
immobilized (Wolter et al., 1997). For example, conformational changes and homooligomerization of the pro-apoptotic protein, Bax, lead to the exposure of mitochondrial
targeting sequences within four of the protein’s nine helices (N. M. George, Targy,
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Evans, Zhang, & Luo, 2010). However, despite the importance of Bcl-xL in preventing
apoptosis, the specific mechanism of how it is translocated from the cytoplasm to the
MOM remains poorly understood. Recent studies demonstrate the role of membrane
trafficking in protein delivery to the MOM (Farmer et al., 2018; Farmer et al., 2017; Tang
et al., 2015; W. Wang et al., 2017); accordingly, we hypothesized that a population of BclxL might also be regulated by endocytic membrane trafficking proteins.
We first tested whether Bcl-xL could be found in a complex with other endocytic
regulatory proteins. Given the established interaction between Bcl-xL and Drp1 (Li et al.,
2013), and between Drp1 and the retromer complex, (W. Wang et al., 2017; W. Wang et
al., 2016) and the growing number of trafficking pathways regulated by the retromer
(Farmer et al., 2018; Farmer et al., 2017; Tang et al., 2015; W. Wang et al., 2017), we tested
if Bcl-xL interacted with the retromer complex. As demonstrated, antibodies to VPS26
immunoprecipitated detectable levels of endogenous VPS26 protein (Figure 3.1A; low
and medium exposures), as well as endogenous Drp1 (Figure 3.1A; high exposure) and
endogenous Bcl-xL (Figure 3.1A; low and medium exposures). Antibodies to Bcl-xL
pulled down endogenous Bcl-xL (Figure 3.1A; low and medium exposures), as well as
VPS26 (Figure 3.1A; low and medium exposures) and Drp1 (Figure 3.1A; high
exposure), whereas control immunoglobulins (Ctl) did not pull down any detectable
VPS26, Bcl-xL, or Drp1. Furthermore, immunoprecipitation with antibodies against
MICAL-L1, an endocytic regulatory protein that interacts with the retromer (Zhang,
Reiling, et al., 2012), also pulled down Bcl-xL in addition to the retromer
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Figure 3. 1
Bcl-xL resides in a protein complex with members of the retromer and DRP1. (A)
HeLa cell lysates were subjected to immunoprecipitations with anti-VPS26, anti–BclxL, or control IgG, and immunoblotted with antibodies against Drp1, VPS26, and
Bcl-xL. Three different exposures of the same immunoblot are depicted: low,
medium, or high exposure. Gels depicted are representative of three independent
experiments showing similar results. Densitometric analysis from these experiments
shows that 1) compared with the level of VPS26 precipitated with anti-VPS26
(defined as 100%), 41–66% of VPS26 precipitates with anti–Bcl-xL, and 2) the level of
DRP1 precipitated by anti–Bcl-xL ranges from ∼50 to 90% of that precipitated by
anti-VPS26. (B) HeLa cell lysates were subjected to immunoprecipitations with anti–
Bcl-xL, anti–MICAL-L1, or control IgG, and immunoblotted with antibodies against
MICAL-L1, VPS35, VPS26, and Bcl-xL. Gel depicted is representative of three
individual experiments showing similar results. Densitometric analysis from these
experiments shows that 1) the ratio of VPS26:Bcl-xL precipitated with anti–Bcl-xL is
0.660+/− 0.110, which is very similar to the ratio of VPS35:Bcl-xL precipitated with
anti–Bcl-xL (0.6866+/− 0.169), and 2) the ratio of VPS26:MICAL-L1 precipitated with
anti–MICAL-L1 (0.589+/− 0.215) is similar to the ratio of VPS35:MICAL-L1
precipitated with anti–MICAL-L1 (0.607+/− 0.129). (C) Efficacy of DRP1 depletion is
demonstrated by immunoblotting lysates from Mock- or DRP1-depleted HeLa cells
with anti-DRP1, and using GAPDH as a loading control. (D) Densitometric
quantification of DRP1 protein levels in either Mock- or DRP1-siRNA treatment.
Error bars denote SD. p values were determined by the Student’s one-tailed t test. n =
3. (E) HeLa cells were treated with either Mock- or DRP1-siRNA,
immunoprecipitated with antibodies against Bcl-xL, and immunoblotted with
antibodies against VPS35, VPS26, and Bcl-xL. Gel depicted is representative of three
individual experiments showing similar results. (F) Densitometric quantification of
VPS35 or VPS26 protein levels immunoprecipitated by anti–Bcl-xL in the presence or
absence of DRP1. Error bars denote SD. p values were determined by the Student’s
one-tailed t test. n = 3. Used with permission from MBoC (Farmer et al., 2019).
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proteins (Figure 3.1B). These experiments support the idea that Bcl-xL partially resides
in a protein complex containing the retromer complex and MICAL-L1.
Since Drp1 interacts with both Bcl-xL and the retromer complex, we next asked
whether Drp1 mediates the interaction between Bcl-xL and the retromer. To answer this
question, HeLa cells were depleted of Drp1 by siRNA transfection (Figure 3.1C,
quantified in 3.1D), and the Drp1 lysate was used to perform a pull down with
antibodies against Bcl-xL. As anticipated, anti-Bcl-xL was able to pull down endogenous
Bcl-xL in the mock- and Drp1-depleted lysates (Figure 3.1E, quantified in 3.1F).
However, upon depletion of Drp1, anti-Bcl-xL still pulled down VPS26 and VPS35
subunits (Figure 1E, top and middle panels, quantified in F). Similar to the anti-Bcl-xL
pull down, depletion of VPS26, which led to a concomitant reduction of VPS35, did not
prevent the pull down of Drp1 by Bcl-xL (data not shown). Overall, these experiments
support the notion that Bcl-xL interacts with the retromer complex and MICAL-L1 in a
Drp1-independent manner.
14.2 Bcl-xL localizes to endocytic vesicles positive for the retromer
Since Bcl-xL interacts with several subunits of the retromer complex and
interaction partners of the retromer, we hypothesized that the retromer serves as a
regulator of Bcl-xL translocation from the cytosol to the MOM. Given that the ratio of
Bcl-xL in the cytoplasm versus the MOM-bound Bcl-xL does not change under apoptotic
conditions (Wolter et al., 1997), any slight change in the balance of the cytosolic-tomitochondrial Bcl-xL might be physiologically important. Accordingly, we postulated
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that if a pool of Bcl-xL was translocated to the MOM by the retromer complex, we would
visualize Bcl-xL associated with retromer-positive vesicles. To test this, we transfected
RPE cells with mCherry-tagged Tom20 N-terminal 10 residues as a mitochondrial
membrane marker and then sequentially immunostained the cells with antibodies
against endogenous Bcl-xL and VPS26 (Figure 3.2 and 3D images in Figure 3.3). As
demonstrated, populations of Bcl-xL were observed on VPS26-positive vesicles (Figure
3.2A, inset in B, E, and H), and interestingly, these vesicles are almost completely devoid
of the Tom20 MOM marker. However, most of the Bcl-xL was seen colocalized with the
Tom20 and devoid of the VPS26 staining (Figure 3.2A, inset C, E, and F). When
quantified, approximately 65% of the Bcl-xL was localized with mitochondria while less
than 30% was on VPS26-positive vesicles (Figure 3.2D). Furthermore, endogenous
VPS35 displayed approximately 85% overlap with VPS26 as expected, as well as ~25%
colocalization with Bcl-xL (Figure 3.4). To further characterize what type of endosomes
these were, we also stained the cells for Rab5 and EEA1, two early endosome markers,
and observed nearly 20% of the Bcl-xL with Rab5, but little or no colocalization was seen
with EEA1 (Figure 3.5). These data illustrate for the first time a population of Bcl-xL that
localizes with a subset of endosomal vesicles that contain the retromer and Rab5, further
suggesting the possibility that retromer plays a role in translocation of Bcl-xL to the
MOM.
14.3 Depletion of VPS35 or MICAL-L1 results in decreased-mitochondrial Bcl-xL
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Figure 3. 2
Bcl-xL localizes to endocytic vesicles containing the retromer. (A) RPE1 cells were
transfected with the N-terminal 10 residues of the mitochondrial outer membrane
protein (Tom20) tagged with mCherry (mCh-Tom20; red), and immunostained with
VPS26 (blue) and Bcl-xL (green). Images shown are 3D snapshots of serial z-sections.
Channels were split, showing the individual protein localization patterns (right
panels). Regions of interest are highlighted with dashed boxes labeled as 1 or 2, and
they correspond to the inset images depicted in B and C. Scale bar = 10 μm. (B) Inset
area 1 from A. Arrows denote vesicles containing VPS26 (blue) and Bcl-xL (green)
but lack mCh-Tom20 (red). Channels were split, showing the individual protein
localizations. Scale bar = 2 μm. (C) Inset area 2 from A. Dashed circles show areas
where Bcl-xL (green) is colocalized with mCh-Tom20 (red), but not VPS26 (blue).
Channels were split, showing the individual protein localizations. Scale bar = 2 μm.
Images portrayed are representative of three independent experiments (quantified in
D). (D) The colocalization threshold analysis tool in Fiji ImageJ was used to quantify
the colocalization between Bcl-xL and mCh-Tom20, Bcl-xL and VPS26, or mChTom20 and VPS26. Data are presented as a mean, and error bars indicate SD. n = 3.
(E) A single representative RPE1 cell transfected with mCh-Tom20 (red), and
immunostained with VPS26 (blue) and Bcl-xL (green). The image shown is a 3D
snapshot of serial z-sections. Blue arrows depict VPS26 and Bcl-xL colocalization,
whereas yellow arrows depict Bcl-xL and Tom20 colocalization. Scale bar = 10 μm.
(F–H) Individual two-channel images from E are shown depicting the colocalization
between Tom20 and Bcl-xL (F), VPS26 and Tom20 (G), and between Bcl-xL and
VPS26 (H). Used with permission from MBoC (Farmer et al., 2019).
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Figure 3. 3
Bcl-xL and VPS26 localize to common vesicles. RPE1 cells were fixed,
permeabilized and immunostained with antibodies to detect endogenous VPS26
(green) and endogenous Bcl-xL (red). Serial z-sections were obtained every 0.4 μm
and a 3D rotation was made from the 8 micrographs (see Video 1). The top image
represents the initial micrograph prior top rotation, with arrows marking several BclxL and VPS26-containing vesicles. The middle and bottom images denote rotations
of 45 and 180 degrees, respectively, and arrows mark the same vesicles seen in the
initial image. Used with permission from MBoC (Farmer, O'Neill, Naslavsky, Luo, &
Caplan, 2019).
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Figure 3. 4
Bcl-xL localizes to endocytic vesicles containing VPS35. (A) RPE1 cells were
immunostained with antibodies against VPS26 (green) and VPS35 (red) and serial zsections were obtained. The images depicted are 3D snapshots. Dashed regions of
interest correspond to the insets on the 3 right-hand panels. Inset channels were split,
showing the individual protein localization patterns with white arrows depicting
vesicles containing VPS26 and VPS35 containing vesicles. Scale Bar= 10 μm, (2 μm;
inset). (B) RPE1 cells were immunostained with antibodies against Bcl-xL (green) and
VPS35 (red) and serial z-sections were obtained. The images depicted are 3D
snapshots. Dashed regions of interest correspond to the insets on the 3 right-hand
panels. Inset channels were split, showing the individual protein localization
patterns with white arrows depicting vesicles containing Bcl-xL and VPS35
containing vesicles. Scale Bar= 10 μm, (2 μm; inset). (C) The co-localization threshold
analysis tool in FIJI ImageJ was used. Data is presented as a mean, and error bars
indicate standard deviation. n=3. Used with permission from MBoC (Farmer et al.,
2019).
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Figure 3. 5
Bcl-xL localizes to Rab5-containing vesicles. (A) 3D snapshot of RPE1 cells
immunostained with antibodies against Bcl-xL (red) and Rab5 (green). The dashed
region of interest corresponds to the inset to the right. Arrows in the inset depict
vesicles containing Bcl-xL (red) and Rab5 (green). Scale Bar= 10 μm, (2 μm; inset).
(B) 3D snapshot of RPE1 cells immunostained with antibodies against Bcl-xL (red)
and EEA1 (green). The dashed region of interest corresponds to the inset to the
right. Scale Bar= 10 μm, (2 μm; inset). (C) The co-localization threshold analysis tool
in FIJI ImageJ was used to quantify the co-localization between Bcl-xL and Rab5 and
between Bcl-xL and EEA1. Data is presented as a mean, and error bars indicate
standard deviation. n=3.
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The retromer is a scaffold and endocytic membrane complex responsible for the
trafficking of a variety of proteins including the mannose 6-phosphate receptor, iron
transporter DMT1-11/Slc11a2, and the Wnt transport protein Wntless/MIG-14 (Arighi et
al., 2004; Eaton, 2008; Tabuchi et al., 2010). In each case, interference with retromer
function leads to mislocalization (Eaton, 2008; Tabuchi et al., 2010) or occasionally to
reduced expression levels of its cargo, possibly due to degradation (Arighi et al., 2004).
Given that the these cargos are mislocalized or degraded when the retromer is
dysfunctional, we hypothesized that if the retromer is responsible for trafficking Bcl-xL,
we should see an impact on Bcl-xL localization or levels when the retromer is disrupted.
In order to test this, we treated RPE cells with siRNA specific for VPS35 or the retromer
interaction partner, MICAL-L1, and compared the Bcl-xL to cells that were mocktreated. Depletion of VPS35 did not have an impact on the total Bcl-xL protein levels
(data not shown). However, mock-treated cells displayed the majority of Bcl-xL on
mitochondria (Figure 3.6, top panel, quantified in B), while VPS35- or MICAL-L1depleted cells (Figure 3.6C and D) had significantly more observable non-mitochondria
associated Bcl-xL (Figure 3.6, middle and bottom panels [Bcl-xL in red]). Moreover,
depletion of VPS35 led to an increased ratio of non-mitochondria associated Bcl-xL as
determined by immunoblotting mitochondrial enriched fragments (Figure 3.6E,
quantified in Figure 3.6F). Further testing did not suggest that the non-mitochondrial
Bcl-xL observed when depleting VPS35 or MICAL-L1 was interacting with any
endocytic or membrane markers (data not shown). Given the ability of Bcl-xL to
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Figure 3. 6
Loss of VPS35 or MICAL-L1 leads to increased non-mitochondrial Bcl-xL. (A)
RPE1 cells were subjected to Mock-, VPS35-, or MICAL-siRNA, immunostained with
antibodies against Tom20 (green) and Bcl-xL (red), and serial z-sections were
obtained. The images depicted are 3D snapshots. Dashed regions of interest
correspond to the insets in the three right-hand panels. Inset channels were split,
showing the individual protein localization patterns. Scale bar = 10 μm, (2 μm; inset).
(B) Quantification of the mean number of non-mitochondrial-associated Bcl-xL
structures upon Mock-, VPS35-, and MICAL-L1-siRNA treatment. Error bars denote
SD. p values were determined by the Student’s one-tailed t test. n = 3. (C) Efficacy of
the VPS35-depletion is demonstrated by immunoblotting lysates from Mock- or
VPS35-depleted RPE1 cells, with GAPDH as a loading control. (D) Efficacy of
MICAL-L1-depletion is demonstrated by immunoblotting lysates from Mock- or
MICAL-L1–depleted RPE1 cells using GAPDH as a loading control. (E) HeLa cells
were treated with either Mock- or VPS35-siRNA, homogenized, and subject to
immunofractionation with anti-Tom20 to generate an enriched mitochondrial
fraction (Mt) and a non-mitochondrial fraction (Non-Mt). The fractions were
separated by SDS–PAGE and immunoblotted with anti–Bcl-xL and anti-Tom20. (F)
Densitometric quantification of the ratio of non-mitochondrial Bcl-xL vs.
mitochondrial Bcl-xL in either Mock- or VPS35- siRNA treatment. Error bars denote
SD. p values were determined by the Student’s one-tailed t test. n = 3. Used with
permission from MBoC (Farmer et al., 2019).
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oligomerize (Basanez et al., 2001; J. W. O'Neill, Manion, Maguire, & Hockenbery, 2006),
it is possible that Bcl-xL remains in cytoplasmic aggregates as previously observed
(Jeong et al., 2004) but further testing would need to be done to confirm this notion.
Overall, these experiments support the idea that VPS35 and the retromer must be
functional and is at least partially responsible for the translocation of Bcl-xL from the
cytoplasm to the MOM and loss of the retromer leads to increased non-mitochondria
associated Bcl-xL.
14.4 VPS35-depleted cells display an enhanced rate of apoptosis
Under normal physiological conditions, the pro-apoptotic Bcl-2-family protein
Bax is primarily localized to the cytoplasm and there is only a small percentage found on
the MOM (Griffiths et al., 1999; Y. T. Hsu et al., 1997; Wolter et al., 1997). A key
regulatory role of Bcl-xL is to sequester Bax in the cytoplasm and prevent its
translocation to the mitochondrial membrane and/or bind to Bax associated with the
MOM and prevent it from forming pores to release cytochrome c (Manon, Chaudhuri, &
Guerin, 1997; Wolter et al., 1997; Yang et al., 1995). Another pro-apoptotic Bcl-2-family
protein, Bad, is responsible for binding to Bcl-xL (Howells, Baumann, Samuels, &
Finkielstein, 2011) and allowing Bax to freely translocate to the MOM where Bax can
form pores and eventually lead to cell death (Bleicken et al., 2010; Gilmore, Metcalfe,
Romer, & Streuli, 2000; Goping et al., 1998). Additionally, because Bcl-xL localized to the
MOM has the ability to inhibit the formation of pores by dissociating oligomers or by
preventing the insertion of Bax into the membrane (Subburaj et al., 2015; Xu et al., 2013),
even a small decrease of Bcl-xL levels on the MOM could have a significant impact on
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the regulation and rate of cell death. Based on our previous experiments, we
hypothesized that VPS35 depletion decreases the amount of Bcl-xL on the MOM, thus
increasing the rate of apoptosis.
To test this, we examined the recruitment of Bax to the MOM (punctate
structures that form on the MOM and form pores) in VPS35 depleted cells as compared
to mock-treated cells in the presence of the kinase inhibitor and apoptosis inducer
(Belmokhtar, Hillion, & Segal-Bendirdjian, 2001), STS (Figure 3.7). In order to perform
these experiments, we used CRISPR/Cas9 gene-edited HCT 116 cells that were depleted
of endogenous Bax and Bak, but were stably transfected with GFP-tagged Bax (GFP-Bax)
(K. L. O'Neill et al., 2016). GFP-Bax cells were treated mock- or VPS35-siRNA and were
either given no treatment or treated with STS (Figure 3.7A-B). Efficacy of the siRNA
treatment was verified in Figure 3.7C. Additionally, all cells were treated with Z-VAD to
prevent the cells from undergoing complete apoptosis and detachment before we could
image them. As anticipated, the GFP-Bax in the cells with no STS treatment displayed
cytosolic GFP-Bax primarily, suggesting that the cells were not undergoing apoptosis
and that Bax was not being recruited to the MOM (Figure 3.7A, left panels). However,
upon STS treatment, although both the mock- and VPS35-siRNA treated cells showed
recruitment of the GFP-Bax to the MOM from the cytoplasm (indicative of a cell
undergoing apoptosis), VPS35 depleted cells showed a significantly higher rate of GFPBax recruitment at the 60-min time point as compared to mock cells (Figure. 3.7A, right
panels, quantified in B). To further address the rate of apoptosis in the presence or
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Figure 3. 7
The rate of Bax activation at the mitochondrial membrane is enhanced in cells
lacking VPS35. (A) CRISPR/Cas9 HCT 116 cells lacking endogenous Bak and Bax,
but expressing stably transfected GFP-Bax, were subject to Mock- or VPS35-siRNA
knockdown, with or without staurosporine (STS) treatment for 60 min. Cells were
fixed and immunostained with anti-Tom20 (red). For micrographs representing the
STS treatment, only GFP-Bax is shown. Scale bar = 10 μm. (B) Quantification of the
mean percentage of Mock- or VPS35-siRNA–treated cells displaying GFP-Bax
activation upon STS treatment. Error bars represent SD. p value was determined by
the Student’s one-tailed t test. n = 3. (C) Efficacy of the VPS35-siRNA treatment is
demonstrated by immunoblotting lysates from Mock- or VPS35-depleted
CRISPR/Cas9 HCT 116 cells with anti-VPS35. GAPDH was used as a loading control.
(D) CRISPR/Cas9 HCT 116 cells lacking endogenous Bak and Bax, but expressing
stably transfected GFP-Bax, were subject to either Mock- or VPS35-siRNA treatment
for 48 h, and treated acutely with STS for 0, 30, or 60 min. Lysates from each
treatment were analyzed by immunoblotting for Parp1 to assess cleavage over time,
and immunoblotting with anti-VPS35 was used to verify the siRNA treatment
efficacy. GAPDH was used as a loading control. (E) Densitometric representation of
the data from D was done using ImageJ to calculate the ratio of Parp1:GAPDH
between Mock- and VPS35-siRNA–treated cells. Data are presented as a mean, and
error bars indicate SD. p values were determined by the Student’s onetailed t test. n = 3. Used with permission from MBoC (Farmer et al., 2019).
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absence of VPS35, we performed biochemical assays to look at Parp1 cleavage (S. H.
Kaufmann, Desnoyers, Ottaviano, Davidson, & Poirier, 1993; Tewari et al., 1995) at three
different time points (Figure. 3.7D-E). Based on our previous experiment, as anticipated,
we observed a significant increase in the rate of full-length Parp1 over 30-60 min of STS
treatment compared to the mock-treated cells induced with STS (Figure. 3.7D-E). We
verified the loss of full-length Parp1 by measuring the ratio of Parp1:GAPDH (loading
control) and found a significant decrease in the full-length Parp1 in VPS35 depleted cells
after 30 and 60 min of STS treatment compared to the mock-treated cells (Figure. 3.7E).
These data are consistent with the idea that the retromer is at least partially responsible
for translocating Bcl-xL to the MOM from the cytosol, and when VPS35 is depleted, the
rate of apoptosis is enhanced due to Bcl-xL not being able to inhibit Bax appropriately.
15. SUMMARY AND CONCLUSIONS
The tight control that Bcl-xL exerts over Bax-driven pore formation at the MOM
and apoptosis hints at the significance of regulating its localization. Despite the crucial
role of Bcl-xL in preventing apoptosis, although studies have addressed other Bcl-2family protein recruitment to the MOM (Desagher et al., 1999; Eskes, Desagher,
Antonsson, & Martinou, 2000; Wolter et al., 1997) or Bcl-xL insertion into membranes
(Adams & Cory, 1998; Y. T. Hsu et al., 1997; T. Kaufmann et al., 2003; Schinzel,
Kaufmann, & Borner, 2004), to date few studies have addressed the mechanisms by
which Bcl-xL is translocated to the MOM from the cytosol.
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In Chapter III, we identified a novel function for the retromer in partially
controlling the translocation of Bcl-xL from the cytosol to the MOM where Bcl-xL then
can prevent Bax pore formation. We demonstrated that Bcl-xL resides in a complex
containing components of the retromer and MICAL-L1 in a Drp1-independent
mechanism, along with observing vesicles that contained both Bcl-xL and the retromer
or Rab5. Since Bcl-xL interacts and colocalizes with retromer-positive endosomes, it
raises the question whether the retromer plays a role in regulating the localization of BclxL in the cell. To answer this, we depleted VPS35 from cells and demonstrated that
cytosolic Bcl-xL was increased compared to the mock-treated cells, suggesting that less
Bcl-xL was on the MOM to prevent apoptosis. To determine if the change in localization
of Bcl-xL impacts its overall ability to prevent apoptosis, we induced apoptosis with STS
in the presence or absence of VPS35. These data showed that when VPS35 is depleted,
the rate of Bax recruited to the MOM is significantly faster and full-length Parp1
cleavage occurs at a quicker rate, suggesting that VPS35 is at least partially responsible
for controlling apoptosis through regulation of Bcl-xL translocation.
In summary, Chapter III describes a model in which disruption of the retromer
complex by depleting VPS35 leads to reduced Bcl-xL at the MOM, causing enhanced
Bax-mediated pore formation, cytochrome c release, and downstream apoptotic events
upon STS treatment, and an enhanced rate of apoptosis (Figure. 3.8). Overall, this study
highlights a novel role for the retromer, an endosomal protein complex, in the
localization of Bcl-xL to the MOM, thus forging a link between endocytic regulation and
apoptosis.
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Figure 3. 8
Model for the role of retromer in regulating Bcl-xL’s translocation to the
mitochondrial membrane and impact on staurosporine-induced apoptosis. Under
physiological conditions (top), staurosporine treatment induces Bax translocation to
the mitochondrial membrane. Because Bcl-xL is constitutively transported to the
MOM, Bax pore formation is inhibited and slowed by Bcl-xL, but when sufficient Bax
pore formation occurs, Cyt c is released and apoptosis occurs. Upon VPS35
knockdown (bottom), there is impaired retromer complex generation and decreased
constitutive transport of Bcl-xL to the MOM. Accordingly, upon staurosporine
treatment there is less inhibition of Bax by Bcl-xL, leading to more rapid Bax pore
formation and an increased rate of apoptosis. Used with permission from MBoC
(Farmer et al., 2019).
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16. SUMMARY
Overall, my work has uncovered several novel functions for endocytic regulatory
proteins in non-classical endocytic pathways and on organelle biogenesis/homeostasis.
In my first body of work, we demonstrated that EHD1 and Rabankyrin-5 play a role in
mitochondrial homeostasis. Depleting EHD1 or Rabankyrin-5 results in mitochondria
that are significantly longer and more interconnected, similar to what is observed upon
Drp1- or Dyn2-depletion. Given that EHD1 is an ATPase with functional and structural
homology to the Drp1 and Dyn2 GTPases, we hypothesized that EHD1 plays a direct
role in mitochondrial fission alongside Drp1 and Dyn2. However, we did not observe
significant localization of EHD1 to the mitochondrial membrane, and upon EHD1depletion, cells nevertheless underwent staurosporine-induced mitochondrial fission (as
opposed to Drp1- and Dyn2-depletion). Prior studies had shown that VPS35, an
interaction partner of EHD1 and Rabankyrin-5, plays a role in mitochondrial
homeostasis through two potential pathways. The first one is by regulating the ubiquitin
ligase Mul1. Mul1 interacts with VPS35 which must release Mul1 from this interaction in
order to facilitate the trafficking of Mul1 to the mitochondrial membrane, where it
ubiquitinates the fusion-promoting protein, Mfn2, and targets it for proteasomal
degradation (Tang et al., 2015). If EHD1 and Rabankyrin-5 play a role in this pathway, a
difference in Mfn2 protein levels would be expected upon EHD1- or Rabankyrin-5depletion. However, upon EHD1- or Rabankyrin-5-depletion, Mfn2 protein expression
remained unchanged. This suggested that EHD1 and Rabnakyin-5 most likely play an
upstream regulatory roles. The second potential mechanism by which VPS35 may
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regulate mitochondrial homeostasis is by interacting with and removing inactive Drp1
from the mitochondrial membrane and thus promoting mitochondrial fission by freeing
up receptors for active Drp1 (W. Wang et al., 2017). Under this scenario, alterations in
VPS35 function, potentially by depleting EHD1 or Rabankyrin-5, would result in
impaired fission, resulting in an elongated and static mitochondrial network. Indeed, we
demonstrated that upon EHD1-depletion, VPS35 protein levels were significantly
reduced. Surprisingly, Rabankyrin-5-depletion did not result in the same reduction of
VPS35 protein levels. However, we demonstrated that upon Rabankyrin-5 depletion,
VPS35 becomes sequestered in the Golgi region. Regardless, in both cases, VPS35 was no
longer capable of removing inactive Drp1 from the mitochondrial membrane, thus
resulting in an elongated and static mitochondrial network. Overall, in this study we
provide a mechanism by which EHD1 and Rabankyrin-5 play a regulatory role in
mitochondrial fission upstream of Drp1 and Dyn2 by controlling VPS35 expression or
localization, respectively.
In my second body of work, we found that the retromer plays a critical role in
regulating the translocation of Bcl-xL to the mitochondrial membrane where it functions
as an inhibitor of apoptosis. Despite the tight control that Bcl-xL exerts over Bax- and
Bak-driven pore formation, few studies have previously studied the mechanisms by
which it is translocated to the MOM. In this study, we demonstrated for the first time
that Bcl-xL physically interacts with VPS35 and retromer subunits in a Drp1independent manner. Furthermore, the retromer and Bcl-xL colocalize on vesicles that
are distinct from the Bcl-xL that colocalizes with mitochondria. Significantly, the loss of
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VPS35 via siRNA both reduces the mitochondrial-localized Bcl-xL, and as a result,
increases the rate of Bax activation and cleavage of Parp1 upon staurosporine-induced
apoptosis. While our studies suggest that only a portion of Bcl-xL is translocated to the
MOM by the retromer, given the significance of Bcl-xL in the regulation of apoptosis,
this previously uncharacterized pathway for the delivery of Bcl-xL to the MOM may
have potentially significant consequences. Our data supports a mechanism in which
depletion of the retromer complex subunit VPS35 leads to reduced Bcl-xL at the MOM,
causing enhanced Bax-mediated pore formation and Cyt c release upon staurosporine
treatment, and an enhanced rate of apoptosis. Overall, this study highlights a novel role
for the retromer, traditionally known as an endocytic regulatory protein complex, in the
localization of Bcl-xL to the MOM, thus generating a link between endocytic regulation
and apoptosis.
17. FUTURE DIRECTIONS
17.1 Chapter II future directions
An increasing number of studies have begun to focus on the indirect regulation
of mitochondrial homeostasis proteins, adding to the complexity of mitochondrial
regulation in normal and disease state cells. Work from Chapter II further solidified the
notion that endocytic regulatory proteins play a significant role in regulating
mitochondrial fission. Specifically, EHD1 is responsible for stabilizing the protein
expression of VPS35 and if EHD1 is depleted, VPS35 protein expression is significantly
decreased. Previously, data published form our lab has identified a complex containing
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the proteins EHD1, Rabankyrin-5, and the retromer components, VPS35 and VPS26
(Zhang, Reiling, et al., 2012). However, whether the interactions between EHD1 and the
retromer are direct or mediated via other proteins, such as Rabankyrin-5, has yet to be
determined. Moreover, our data indicates that Rabankyrin-5-depletion has a similar
impact on mitochondrial morphology to that of EHD1-depletion, suggesting that both
proteins are needed to regulate inactive Drp1 removal from MOM by vesicles containing
VPS35 and the retromer (Farmer et al., 2017). We have shown that EHD1 interacts
directly with Rabankyrin-5, and we predict that EHD1 interacts indirectly with the
retromer, likely mediated by Rabankyrin-5 or potentially another direct EHD1
interaction partner such as MICAL-L1 or Syndapin2. First, to determine if the interaction
between EHD1 and the retromer components, VPS26 and VPS35, is direct or indirect, we
will use purified GST-EHD1 and HIS-tagged retromer proteins. A GST-pull down assay
will be done incubating equimolar concentrations of purified GST-EHD1, with HISVPS35 or HIS-VPS26. Immunoblotting of precipitated samples will be done. If, as
anticipated, no direct binding is observed, we will first test whether the interaction is
mediated by Rabankyrin-5. To accomplish this, Rabankyrin-5-depleted cells will be used
to perform pull-downs with GST-EHD1 to determine whether retromer subunits fail to
precipitate. If the interaction of the upstream regulators of Drp1 can be elucidated, a
better therapeutic approach can be used for controlling various disease states with
upregulated Drp1 and therefore mitochondrial fission.
Additionally, it is believed that VPS35-containing mitochondrial-derived vesicles
(MDVs) traffic inactive Drp1 from the mitochondrial membrane to the lysosome for
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degradation, thus allowing active Drp1 and Dnm2 to catalyze fission. However, how
these vesicles undergo fission from the MOM is currently unknown. Therefore, we
predict that EHD1 will be needed to generate the MDVs required for Drp1 removal. To
test this idea, we will use confocal microscopy to analyze changes in MDVs upon EHD1
KD. Cells will be subjected to either mock- or EHD1-siRNA transfection. We will
measure the number of MDVs containing Drp1 and/or VPS35 upon EHD1 KD.
Observing significantly fewer MDVs in the absence of EHD1 will provide additional
support for the notion that EHD1 is needed for the fission and generation of MDVs to
traffic inactive Drp1 away from the mitochondria.
17.2 Chapter III future directions
To continue our work on chapter III, we will work to determine if Bcl-xL
interacts directly with the retromer or if the interaction is mediated by other endocytic or
apoptotic related proteins. By accomplishing this, we will gain insight into what other
proteins are present with the retromer and Bcl-xL that may also be playing a role in the
translocation of Bcl-xL to the MOM. For example, we might gain insight into the
mechanism required for fission of the budding vesicle containing the retromer and BclxL, potentially by EHD1. In order to test this, we will use purified His-VPS35 or HisVPS26 and GST-Bcl-xL to perform pull-down experiments. In the event that this
experiment does not work, we will examine other potential candidates that might be
mediating the interaction between the retromer and Bcl-xL.
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Furthermore, we will perform live-cell imaging to track the dynamics of the
vesicles containing the retromer and Bcl-xL upon various treatments and conditions to
see what impact they may have on the rate of Bax activation and apoptosis. In tandem
with microscopic dynamic studies, single molecule imaging techniques, such as direct
Stochastic Optical Reconstruction Microscopy (dSTORM) and/or electron microscopy
will be used to perform a detailed analysis of the structure of the vesicles containing BclxL and retromer to gain further insight into the morphology and mechanism behind
apoptosis regulation by endocytic proteins.
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